Leukemia inhibitory factor enhances neurogenin's pro-neural effect during mouse cortical development by Hasan, Sascha
 
Leukemia inhibitory factor enhances neurogenin´s pro-neural 
effect during mouse cortical development 
 
 
Dissertation  
zur Erlangung des Doktorgrades 
der Naturwissenschaften 
 
 
vorgelegt beim Fachbereich Biologie und Informatik 
der Johann Wolfgang Goethe-Universitaet 
in Frankfurt am Main, Deutschland 
 
 
von  
Sascha Hasan 
aus Heidelberg, Deutschland 
 
 
Frankfurt am Main 2007   2
 
 
 
 
 
 
 
 
 
Vom Fachbereich Biologie und Informatik der 
Johann Wolfgang Goethe-Universitaet als Dissertation angenommen 
 
 
 
Dekan: Prof. Dr. R. Wittig 
Gutachter: Prof. Dr. W. Volknandt 
                  Prof. Dr. Y. Sun 
 
Datum der Disputation:  
 
 
 
   3
Table of contents 
 
1  Introduction...............................................................................................6 
1.1  Neural stem cells and cortical development ..............................................7 
1.2                    Intrinsic factors that promote cortical neurogenesis: proneural basic helix-  
                         loop-helix transcription factors.................................................................10 
1.3                    Extrinsic factors that regulate cortical development.................................15 
1.4                    Mechanisms by which neurogenin inhibits gliogenesis and promotes                       
                         neurogenesis..............................................................................................16 
1.5                    The role of SWI/SNF chromatin remodeling protein Brg1 in promoting                               
                         neurogenesis..............................................................................................18 
1.6                    Therapeutic potential of NSCs in neurodegenerative diseases.................19 
1.7                    Overview of project experiments and findings.........................................21 
  
2                       Matherial and methods...........................................................................23 
2.1  Cell culture and reagents...........................................................................24  
2.2  Mice...........................................................................................................25 
2.3  Expression vectors and adenovirus constructions.....................................26 
2.4  PLCγ and PKCδ siRNA............................................................................27 
2.5  Immunocytochemistry...............................................................................28 
2.6  Immunohistochenistry...............................................................................29 
2.7  Western-blot analysis and immunoprecipitation.......................................30 
2.8  Dual luciferase reporter assay..............................................................................31   4
2.9  Chromatin Immunoprecipitation assays...................................................32 
 
3                       Results......................................................................................................36 
3.1  LIF enhances neurogenin’s transcriptional activation in cortical NPCs...37 
3.2                    LIF promotes neurogenesis and inhibits gliogenesis in cortical NPCs in   
                         the presence of Ngn1 and Ngn2 in vitro....................................................40 
3.3                    Potential signaling pathways mediating the neurogenic effect of LIF......42 
3.4  PLCγ/PKC mediate the effect of LIF on neurogenesis..............................45 
3.5  PLCγ/PKC promote association between Ngn1, CBP/p300 and Brg1......47 
3.6  PKCδ might be the mediator of LIF in cortical NPCs during   
neurogenesis..............................................................................................50 
3.7  PLCγ and PKCδ siRNA abolishes the pro-neural effect of Ngn and LIF.53 
3.8  LIF promotes neurogenesis in vivo...........................................................56 
3.9  LIF heterozyogte and knock out mice display less binding of the Ngn1-
CBP cotranscriptional complex to the NeuroD promoter.........................59 
 
4  Discussion.................................................................................................60 
4.1      Novel pro-neurogenic role of LIF during cortical neurogenesis is solely   
                         dependent on the expression of bHLH factors Ngn1 and Ngn2................62 
4.2      LIF promotes CBP-Ngn1 association, leading to enhanced NeuroD  
                         transcription and therefore to increased neurogenesis...............................63 
4.3      LIF-induced PKC activity is necessary for CBP-Ngn association............65 
4.4   The role of Brg1 during mouse cortical neurogenesis...............................68   5
4.5   In vivo evidence for LIF’s pro-neural role during mouse cortical    
                         neurogenesis..............................................................................................69 
4.6      Implication of this work for regenerative medicine..................................71 
 
5      Summary (German)................................................................................73 
6      Reference.................................................................................................78 
7      Acknowledgement...................................................................................93 
8      Lebenslauf................................................................................................94 
9      Declaration...............................................................................................95 
     
   
  
      
 
 
       
 
 
 
 
 
 
   6
 
 
 
 
 
 
Chapter 1 
 
 
 
Introduction 
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1.1 Neural stem cells and cortical development 
 
During mammalian development the major cell types comprising the cerebral 
cortex of the central nervous system (CNS) arise from a single layer of proliferating 
neuroepithelial cells that line the ventricles and form the ventricular zone (VZ). Neurons, 
astrocytes and oligodentrocytes differentiate sequentially from these neural progenitor 
cells (NPSs, also referred to as neural stem cells, NSCs), with most neurons being 
generated before glial cells (Figure 1a; Bayer and Altman, 1991; Sauvageot and Stiles, 
2002; Sun et al., 2003).  
When NPCs are isolated from the embryonic cortex this pattern of 
differentiation is recapitulated in vitro. NPCs can be expanded in culture either as 
monolayers on a coated surface, or as neurospheres, which are clusters of floating cells 
(Johe et al., 1996; Reynolds and Weiss, 1996). When derived from early embryos (e.g., 
mouse embryonic day (E) 10-11) NPCs give rise exclusively to neurons after short-term 
culture, while cortical progenitors isolated after E13-14 become predominantly astrocytes 
under the same culture conditions (Qian et al., 2000). However, to maintain these 
progenitor cells in a proliferating state, mitogenic growth factors, such as basic fibroblast 
growth factor (bFGF), or epidermal growth factor (EGF), must be added to a well-
defined culture medium (Gage et al., 1995). Further, NPCs derived from early embryos 
switch from being predominantly neurogenic to predominantly gliogenic over time in 
vitro, which implies that intrinsic changes can regulate the neural versus glial cell fate 
(Figure 1b; Reynolds and Weiss, 1992; Sauvageot and Stiles, 2002; Sun et al., 2003). 
   8
Figure 1:  Cortical progenitor cells follow an intrinsic developmental sequence in vivo and in vitro.  
(a) The generation of the three cell types within the brain occurs in a temporally distinct yet overlapping 
pattern. (b) In vitro cultures mimic the differentiation pattern seen in vivo, suggesting that these cells are 
intrinsically primed for a given fate at a given developmental period. Long-term cultures of cells isolated at 
E12 will sequentially give rise to neurons, then astrocytes, and finally oligodendrocytes. 
 
Notably, during development, neuroepithelial cells first undergo symmetric, 
proliferative divisions, each of which generates two daughter stem cells (Rakic, 1995; 
McConnell, 1995). As cortical development proceeds, the length of the cell cycle 
increases primarily through the extension of the G1 phase. Concurrently, cells begin to 
undergo asymmetric cell division, and the fraction of cells that begin to differentiate into 
neurons increases, whereas the proportion of cells remaining as progenitors decreases 
(Caviness and Takahashi, 1995).  
Upon cell cycle exit, a cell must migrate out of the ventricular zone (VZ) 
towards the developing neocortex. About 80-90% of cortical neurons arise from the VZ 
of the dorsal telencephalon and migrate radially to their place in the cortex. Although 
radial migration accounts for the bulk of cortical neurons, studies have shown that a 
subpopulation of neurons moves tangentially across the plane of the glial fiber system 
(Figure 2). These cells originate in the subpallium and include the majority of γ-  9
aminobutric acid-expressing (GABAergic) interneurons and some cortical 
oligodentrocytes (Kriegstein and Noctor, 2004; Marin and Rubinstein, 2001). Radial glia, 
which are columnar cells that have their cell body in the VZ but extend their processes to 
the pial surface, function as scaffolding for brain development by guiding developing 
neurons from the VZ to their final destination. In addition, radial glia not only provide the 
primary pathways for directed migration, but also themselves are the neural progenitors 
(Kriegstein and Noctor, 2004). Furthermore, they could give rise to adult subventricular 
zone (SVZ) stem cells that maintain the neurogenic potential in the adult brain (Doetsch, 
2003). However, at about E11, the first group of neurons that migrate out of the 
ventricular zone constitutes the preplate. A subsequent wave of neuronal migration at 
about E13 splits the preplate into two layers: the more superficial marginal zone, which 
consists of the Cajal-Retzius cells born in the first migration wave, and the deeper 
subplate, which consists of the rest of the primordial cells. The development of the 
cerebral cortex progresses with successive waves of migration that position neurons 
within the different layers in the cortical plate (Hatten, 1999) 
 
Figure 2: Primary migration routes.  
Projection neurons migrate radially from the dorsal ventricular zone 
(a). Interneurons expressing GABA originate from the subpallium 
structure - the lateral ganglionic eminence (LGE), medial ganglionic 
eminence (MGE), and anterior entopeduncular area (AEP) - and 
migrate tangentially into the olfactory bulb (b) or the cortex (c and d). 
When they arrive at the cortex, some of these neurons are directed 
towards the VZ before radially migrating into the cortex (d). 
(Ayala et al., 2007)   10
 Interestingly, studies that examine the birth date of neurons have shown that 
each time a new wave of neurons migrates towards the cortical plate, the cells migrate 
past the neurons previously located in the cortical plate and come to rest right below the 
marginal zone. Thus the layers in the cortical plate (future adult layers II-VI) are 
established according to an inside-out pattern, where the earliest waves of neuronal 
migration will go on to form the deeper layer (V-VI), while the last wave of neurons will 
be localized to the more peripheral layer II and III (Marin and Rubinstein, 2003). 
The potential for controlled differentiation into all neuronal tissues makes NSCs 
very attractive for regeneration therapy in the nervous system. There are yet many 
obstacles to overcome and procedures to improve. Direct transplantation of 
undifferentiated NPCs into an injured nervous system may result in uncontrolled 
differentiation that could be counterproductive. To ensure progress in the medical use of 
stem cells increased basic knowledge of the cellular mechanisms that govern the cell fate 
choice made by NSCs will significantly facilitate the development of more effective and 
directed production of the cell types required for specific neural repair purposes.  
 
1.2 Intrinsic factors that promote cortical neurogenesis: proneural basic 
helix-loop-helix transcription factors  
 
At the time of neurogenesis a subset of cortical progenitors becomes restricted to 
a neuronal lineage. It is likely that this restriction involves asymmetric division in which 
one cell is maintained as a NSC, while the other differentiates into a neuron within a few 
rounds of cell division (Caviness and Takahashi, 1995). Recent insights into the   11
molecular mechanisms of cortical development have shown that proliferation, 
specification, and differentiation of cortical NSCs are controlled, to a large degree, by 
transcription factors with basic helix-loop-helix (bHLH) motifs (Figure 3). These are the 
structural motives that mediate DNA binding and form heterodimeric complexes with 
ubiquitously expressed bHLH proteins, or E protein, such as E12 or E47. Through their 
positively charged basic domain, these heterodimers then bind to a core hexanucleotide E 
box element, CANNTG (Gradwohl et al., 1996). To promote neuronal differentiation and 
activate tissue-specific gene expression E-box binding is critical for bHLH proteins (Cau 
et al., 1997).  
 
 
Figure 3: Structure of pro-neural bHLH proteins. 
Schematic representation of the structure of a bHLH 
dimer that is bound to DNA via its basic region. 
(Bertrand et al., 2002) 
 
 
Further, coactivators, such as p300/CBP and PCAF, mediate transcriptional 
activation through their interaction with bHLH heterodimers. These coactivators recruit a 
large complex that includes the basal transcriptional machinery. In addition, coactivators 
facilitate transcription by acetylating histones, leading to the unrevealing of DNA from a 
tightly packed structure to one that is accessible to the transcriptional machinery (Roth at 
al., 2001).    12
It was shown in Drosophila and vertebrates that only a small number of proneural 
bHLH transcription factors are both necessary and sufficient to initiate the development 
of neuronal lineages (Ma et al, 1996; Ross et al, 2003). Three proneural genes 
Neurogenin 1 (Ngn1), Neurogenin 2 (Ngn2), and Mash1, are expressed exclusively in the 
cortical ventricular zone (Guillemont and Joyner, 1993; Lo et al., 1991; Sommer et al., 
1996). While neural progenitors are being specified these bHLH factors are expressed at 
low levels, followed by a transient increase in their expression that results in the initiation 
of neurogenesis. Consistent with this idea, proneural bHLH factors are expressed in the 
ventricular zone, where progenitors begin differentiation, but not in the cortical plate, 
where fully differentiated neurons are situated. While Ngn1 and Ngn2 are expressed in 
the dorsal telencephalon, which gives rise to glutamatergic neurons, Mash1 is 
predominantly expressed in the ventral telencephalon, which gives rise to GABAergic 
and cholinergic neurons, suggesting that different neuronal subtypes are specified by 
different proneural genes (Wilson and Rubinstein, 2000). 
Overexpression of Ngn1, like Mash1, can induce the expression of neuronal 
markers, such as β-tubulin, indicating that either factor can initiate a program of gene 
expression that results in a neuronal phenotype (Sun et al., 2001; Farah et al, 2000).  
However, different bHLH factors seem to activate different signaling cascades. Ngn1 and 
Ngn2, but not Mash1 control expression of neuronal differentiation bHLH factors, such 
as NeuroD, which is necessary for mediating terminal differentiation after neurogenesis is 
initiated (Cau et al., 1997). Like proneural bHLH factors, bHLH differentiation proteins 
act as E-box binding transcriptional activaters, and, when overexpressed, are sufficient to 
induce cell cycle arrest and neuronal differentiation in culture (Farah et al., 2000). The   13
programs of gene expression that are mediated by Mash1 activity in the ventral 
telencephalon are still unknown. By defining the subset of genes that are common to 
Mash1 and Ngn1/Ngn2 versus those that are different to each proneural gene one would 
gain great value in understanding how pan-neuronal and subtype-specific programs of 
gene expression work together to mediate neurogenesis.  
The important role of proneural bHLH factors in the CNS has been supported 
by several knockout studies. Mash1 knockout mice display a loss of GABAergic 
interneurons in the telencephalon (Casarosa et al., 1999, Yun et al, 2002), whereas Ngn1 
or Ngn2 single mutant mice show reduced expression of several transcription factors 
specifically expressed by cortical neurons (Math2,  Nscl1,  NeuroD,  NeuroD2,  Tbr1, 
Tbr2). These transcription factors were even more severely downregulated in Ngn1/Ngn2 
double-knockout mice (Schuurmans et al, 2004). Further, vesicular glutamate 
transporter1 and 2 (VGLU1 and 2), which load glutamate into synaptic vesicles (Fremeau 
et al., 2001), are also downregulated in Ngn mutant mice. Thus Ngns are required to 
activate cortical- and glutamatergic-specific differentiation programs in early-born 
cortical plate neurons, likely acting downstream of cortical patterning genes, such as 
Gli3, Pax6 and Emx2, that are normally expressed in Ngn mutants. In addition, Ngn 
mutant mice show an increase in ventral telencephalic transcription factors in cortical 
progenitors, such as Mash1,  Dlx1 and Dlx2, and an increase in GABAergic neuron 
markers (Schuurmans et al., 2004). When both Ngn2 and Mash1 are disrupted neural 
progenitors switch from producing neurons to becoming astrocytes, further indicating 
that a decrease in proneural bHLH activity leads to an astrocyte fate (Nieto et al., 2001).   14
As shown by our own and other laboratories, Ngn2 knockout mice display 
strong neuronal migration defects, suggesting that bHLH transcription factors have dual 
functions to couple neuronal migration with neurogenesis, enabling newborn neurons to 
migrate (Ge et al., 2006; Hand et al., 2005). Moreover, bHLH genes regulate the 
neurogenic and migratory machineries via partially distinct mechanisms because 
mutations in bHLH genes were found to specifically affect either migration or 
neurogenesis. 
The way the expression of Ngn1/2 and Mash1 is regulated is still not clear. 
Members of the Hes family (for example Hes1 and Hes5) are known bind to N boxes 
(CACNAG) and repress the expression of target genes, such as Mash1 (Chen at al., 1997; 
Davis and Turner, 2001). Recent finding suggest that HMG-box proteins, such as Sox1 
and Sox2, might function upstream of proneural genes inhibiting these genes’ expression 
(Graham et al., 2003). The paired homeodomain transcription factor Pax6 binds to a 
conserved regulatory element on the promoters of Ngn1 and Ngn2 (Scardigli et al., 2003). 
Nevertheless, the signaling pathways and mechanisms that positively regulate the activity 
of proneural factors are largely unknown. Furthermore, we have no knowledge about 
mechanisms that downregulate the expression of proneural genes at a later developmental 
stage.   
Additionally, it was shown that Ngn1, Ngn2 and Mash1 all have consensus 
sequences in the C-terminus that correspond to consensus glycogen synthase kinase 3 
(GSK3) phosphorylation sites. It has been suggested that this may represent a common 
mechanism to regulate the activity of these bHLH factors (Moore et al., 2002). Because 
Wnt and FGF signaling is well known to regulate the activity of GSK3, it is tempting to   15
speculate that extrinsic signals and intrinsic pathways regulate bHLH factors through 
GSK3-mediated phosphorylation. Whether phosphorylation of bHLH factors leads then 
to ubiquination followed by degradation by proteasomes, similar as β-catenin regulation 
by GSK3 phosphorylation, still needs to be explored.  
 
1.3 Extrinsic factors that regulate cortical development 
 
Cortical precursors exhibit distinct biological responses to various extracellular 
stimuli. Proliferation of cortical NSCs is primarily controlled by the action of basic 
fibroblast growth factor (bFGF), which leads to an expansion of the precursor cell 
population (Gosh et al., 1995). 
Differentiation of cortical NSCs into neurons, on the other hand, is controlled by 
neurotrophic factors, such as neurotrophin-3 (NT-3) and brain-derived neurotrophic 
factor (BDNF), and growth factors, such as platelet-derived growth factor (PGDF) (Gosh 
et al., 1995; Menard et al., 2002; Barnabe-Heider et al., 2003). As shown by Menard et al, 
PDGF promotes the generation of neurons in vitro via activation of an MEK-RSK-C/EBP 
(MAP kinase kinase - ribosomal S6 kinase - CAAT enhancer-binding protein) pathway. 
In addition, PDGF inhibits CNTF-mediated gliogenesis, while inhibition of C/EBP-
dependent transcription enhances CNTF-mediated gliogenesis, leading to precocious glia 
cell differentiation. Further, recent findings demonstrate that cortical NSCs express 
BDNF and NT-3, as well as their preferred tyrosine kinsase B (TrkB) and TrkC receptors. 
Moreover, these endogenously produced neurotrophins signal via Trk receptors to 
activate the phosphatidyl inositol-3-kinase (PI3-kinase) and MEK pathways, which have   16
distinct functions, with PI-3 kinase being essential for progenitor survival and MEK for 
the differentiation of neurons but not glia (Barnabe-Heider et al, 2003).  
Additionally, bone morphogenic proteins (BMPs) induce neuronal 
differentiation in primary cultured, early (E11-12), neurogenic cortical progenitors, but 
induce astroglial differentiation in relatively late (E16-17) progenitors (Li et al., 1998; 
Mabie et al., 1999), depending on the presence or absence of Ngn1 (Sun et al., 2001).  
Other astroglial-inducing factors, such as leukemia inhibitory factor (LIF), 
Notch-Delta, and bFGF can initiate the astrocyte differentiation program only in E15 or 
older cortical progenitors, but not in early neurogenic progenitors (Gaiano et al., 2000; 
Ge et al., 2002; Kamakura et al., 2004; Molne et al., 2000; Song and Gosh, 2004; 
Takizawa et al., 2001; Tanigaki et al., 2001; Viti et al., 2003). In E11 CNS neural 
progenitors, both Notch-delta and bFGF function instead as pro-proliferation factors 
(Bartlett et al., 1998; Chambers et al., 2001; Gaiano et al., 2000; Ge et al., 2002; Kuhn et 
al., 1997). 
 
1.4 Mechanisms by which Neurogenin inhibits gliogenesis and promotes 
neurogenesis 
 
The treatment of cortical progenitors with cytokines, such as LIF or CNTF, 
promotes astrocyte differentiation (Bonni et al., 1997; Johe et al., 1996; Park et al., 1999). 
The effect of these cytokines is depended on the Janus kinase (JAK) - Signal Transducers 
and Activators of Transcription (STAT) signaling pathway. Phosphorylation by JAKs 
results in the dimerization and translocation of STATs into the nucleus, where they   17
initiate transcription of astrocyte-specific genes (Bonni et al., 1997; Nakashima et al., 
1999a; Stahl and Yancopoulos, 1994). Additional treatment with BMPs potentiates 
astrocyte differentiation by activating Smad transcription factors, which form a complex 
with STAT1/3 that is bridged by the p300/CBP coactivators (Nakashima et al., 1999b). 
However, our laboratory demonstrated that Ngn1 blocks cytokine-induced astrocyte 
formation by disrupting this STAT1/3-Smad-CBP transcriptional coactivator complex 
(Figure 4; Sun et al., 2001). The interaction of CBP with STAT1/3 is blocked by the 
association of CBP with Ngn1, inhibiting STAT1/3-mediated transcription. In addition 
Ngn1 can also block the phoshorylation of STAT1/3 after cytokine treatment. 
 
Figure 4: Ngn1 inhibits gliogenesis via two different mechanisms. 
By inhibiting STAT1/3 phosphorylation, and by sequestering CBP-Smad1 away from glia specific genes 
Ngn1 inhibits glia cell differentiation. In the absence of Ngn1, CBP/p300 binds to STAT1/3, initiating 
transcription of glia-specific genes, such as GFAP.  If Ngn1 is present, CBP/p300 and Smad1 (separately or 
together) bind to Ngn1 and promote transcription of neuron-specific genes, such as NeuroD.   18
1.5 The role of SWI/SNF chromatin remodeling protein Brg1 in 
promoting neurogenesis 
 
Factors that modulate the chromatin structure, such as chromatin-remodeling 
complexes, histone acetyltransferases (HATs) and deacetylases (HDACs) play important 
roles in transcriptional regulation. The SWI/SNF complex was the first chromatin-
remodeling complex identified and characterized (Kadonaga, 1998; Martens and 
Winston, 2003). It consists of 7-13 subunits and uses energy provided by ATP hydrolysis 
to locally disrupt histone-DNA associations and relocate nucleosomes to alternate 
positions (Kingston and Narlikar, 1999; Whitehouse et al., 1999). In mammalian cells, 
SWI/SWF complexes have either one or two catalytic subunits, Brahma (Brm) or 
Brahma-related gene 1 (Brg1), but not both (Martens and Winston, 2003). It was recently 
demonstrated that Brg1 plays a critical role in primary neurogenesis in Xenopus (Seo et 
al, 2005). Inhibition of Brg1 resulted in an expansion of proliferating NSC and inhibition 
of neuronal differentiation. The studies showed that Brg1 interacts with xenopus Ngn and 
NeuroD, and that the ability of these pro-neural bHLH proteins to promote neurogenesis 
and transactivate their target genes required Brg1 activity. Also, Gerald Crabtree’s group 
(Lessard et al., 2007) showed in a recently published paper that Brg1, depending on the 
subunit it is bound to,  is necessary for NPC proliferation as well as neuronal 
differentiation. When Brg1 was bound to Brg/Brm-associated factor 45a (BAF45a) or 
BAF53a, NPCs remained in a proliferative state by inducing the expression of several 
components of the Notch signaling pathway. On the other hand, as soon BAF45b/c or 
BAF 53b bound to Brg1 neuronal differentiation was induced.   19
1.6 Therapeutic potential of NSCs in neurodegenerative diseases 
 
Neural stem cells (NSCs) of the central nervous system (CNS) have recently 
received much attention and interest because of their therapeutic potential for 
neurological disorders. An important issue is the potential of NSC to differentiate into 
different neuronal subtypes, which makes these cells applicable for replacement therapies 
of diseases, such as Parkinson’s disease, Huntington’s disease, Alzheimer’s disease and 
stroke. 
Parkinson disease is characterized by the progressive loss of dopominergic 
neurons in the substantia nigra of the midbrain. Transplantation of dopamine (DA) 
neuron precursors into the brain of patients suggests that neuronal replacement therapy 
may be a possible treatment (Lindvall et al., 2004). However, transplantation trials with 
Parkinson disease patients raised
  concerns about both the therapeutic benefit and the 
consequences
 of fetal cell grafting (Freed, et al., 2001; Olanov et al., 2003; Hagell et al., 
2002). For further development of a
 transplantation therapy a constant source of DA 
neurons is necessary, and clear evidence of DA function in preclinical models must be 
shown. Additional knowledge of neuron developmental might be helpful in effectively 
differentiating NSC into neurons, and ultimately into a certain neuronal subtype.  
Huntington’s disease (HD) is a fatal disorder that is characterized by chorea 
(excessive spontaneous movements) and progressive dementia. It is caused by the death 
of projection neurons in the striatum. Stem cell therapy aims to restore or preserve brain 
function by replacing and protecting straital neurons, a strategy that might be insufficient 
because patients also suffer progressive neocortical degeneration. In animal HD models,   20
cell replacement, using fetal striatal neurons, promotes functional recovery, and some 
evidence from clinical trials indicate that this can also occur in patients (Lindvall et al., 
2004).  
Alzheimer’s disease (AD) is the most common form of degenerative dementia 
that affects many elderly people with progressive symptoms of memory loss (Marin et 
al., 2002; Rossner et al., 1994; Selkoe, 1999). AD is characterized by neuronal and 
synaptic loss throughout the brain, involving the basal forebrain cholinergic system, 
amygdala, hippocampus and several cortical areas (Auld et al., 2002). The pathology of 
AD includes neuritic plaques composed of beta-amyloid peptide (Aβ), and neurofibrillary 
tangles composed of hyperphosphorylated tau. Current therapies, such as treatment with 
acetylcholinesterase inhibitors to enhance cholinergic function, provide only partial and 
temporary easing of symptoms. In theory, transplanting cholinergic neurons generated 
from NSC in vitro could prevent cognitive decline caused by the degeneration of basal 
forebrain cholinergic neurons. But to provide a long-lasting benefit, this approach would 
require the existence of functional target cells that are like to be damaged over time. 
However, to counteract cholinergic neuronal death, basal forebrain grafts of fibroblasts 
that produce nerve growth factor (NGF) have been of some benefit in patients with AD 
(Tuszynski et al., 2005).  
Stroke is caused by the blockage of a cerebral artery, leading to the loss of 
neurons and glia cells, which causes motor, sensory or cognitive impairments. However, 
it was demonstrated that transplantation of human fetal NSC into the brains of stroke-
damaged rates resulted in migration of new neurons towards the damaged area (Kelly et 
al., 2004). Furthermore, studies showed that monkey ES-cell-derived NSC transplanted   21
into the brains of mice after stroke can differentiate into neurons and glia cells and re-
establish connections with target areas (Hayashi et al., 2006). 
 
1.7 Overview of project experiments and findings 
 
During mammalian CNS development, neural progenitor cells switch from early 
neurogenic to late gliogenic state (Sauvageot and Stiles, 2002). Various extracellular 
factors are required to regulate various processes during development. Interestingly, my 
studies revealed that one common factor, LIF, can serve different developmental 
functions by activating different down-stream signaling pathways in a cell-context 
dependent manner. Our laboratory has previously reported that, during cortical 
development, LIF-induced JAK-STAT signaling is essential for glia cell differentiation, 
but that Ngn1 can counteract this signaling pathway and induce transcription of neuronal 
markers. However, applying luciferase assay, western blot and immunocytochemistry our 
results demonstrated that LIF not only promotes gliogenesis, but also neurogenesis in 
early as well as in late mouse cortical NPCs, when Ngn1/2, but not Mash1, is 
expressed/overexpressed. Further molecular and biochemical analyses indicated that LIF 
enhances the association between Ngn1 and its transcriptional co-activator CBP/p300. In 
addition, LIF enhances association between Ngn1 and the SWI/SNF chromatin-
remodeling complex subunit Brg1 in order to activate gene transcription leading to 
neuronal differentiation. To identify the mechanism by which LIF promotes neurogenesis 
three signaling pathways were examined: the Ras-MAP kinase, the PI3 kinase-Akt, and 
the PLCγ-PKC pathway in Ngn1-overexpressing and control NPCs. Administration of   22
small molecule drugs and siRNA to inhibit individual pathways showed that LIF 
specifically promotes neurogenesis via PLCγ-PKC. More specifically, PKCδ seems to be 
a likely candidate as mediator for the pro-neural LIF effect in NPCs. Furthermore, 
chromatin-immunoprecipitation (ChIP) data demonstrated that LIF promotes the 
association of the Ngn1/CBP transcriptional complex to the NeuroD promoter.  
To observe the in vivo relevance of LIF with regards to neurogenesis, 
brains/cortices of E13, LIF knockout, heterocygote, and wildtype mice were isolated and 
compared. While immunohistochemistry of coronal brain section showed neuron 
expression in all three genotypes, western blot analysis, a more quantitative method, 
showed that LIF knockout and heterocygote mice express less neurons as suggested by a 
decreased protein level of neuronal markers, such as TuJ1 and MAP2a/b. In addition, 
ChIP analysis demonstrated reduced binding of the Ngn1-CBP transcriptional complex to 
the NeuroD promoter.  
These experiments elucidate an elegant regulation mechanism by which a single 
extracellular factor may promote opposite cell fates solely depending on the presence and 
absence of an intracellular factor, an observation, which might have important 
implications in directing the differentiation of neural stem cells to neurons that can be 
used for neural repair. 
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2.1 Cell culture and reagents 
 
To prepare E11/E12 cortical progenitor cell cultures we used timed pregnant Balb/c mice. 
Mouse embryo cortices were dissected out in hank’s balanced salt solution (HBSS, 
Invitrogen) and dissociated mechanically by triturating using a flame-polished pasture 
pipette. Dissociated cells were plated onto poly-ornithine (PO, Sigma, 15 μg/ml in H2O) 
and fibronectin (FN, 2 μg/ml in phosphate-buffered saline or PBS) coated 10 cm dishes at 
a density of 1 million cells/dish in serum-free medium (DMEM/F12 supplemented with 
B27 supplement [Invitrogen], penicillin-streptomycin [50 μg/ml and 50 U/ml, 
respectively]). Basic fibroblast growth factor (bFGF, PeproTech) at a final concentration 
of 10 ng/ml was added to the culture every day to expand the progenitor cell population. 
After 5-7 days in culture, the cells were scraped off the plate and plated onto a new 
PO/FN-coated plate at a density of 1 million cells per dish, and cultured under the same 
condition as the primary cells. After two passages (1-2 weeks), the cultures were 
relatively homogenous, composed predominantly of Nestin-positive multipotent 
progenitor/stem cells. 
For immunocytochemistry and immunoblotting analyses of differentiated NSCs, cells at 
various passages were plated on PO/FN-coated glass coverslips at a density of 25,000-
50,000 cells per well in a Costar 24-well plate, and on PO/FN coated 6-well plates at a 
density of 1 million cells per well. bFGF was added at the time of plating. Usually, 1-2 
days after culturing, cells were treated with Ngn-Adenovirus and LIF (100ng/ml, R&D 
Systems) over night (about 24 hours), then fixed and subjected to immunostaining, or 
lysed and proteins extracted.    25
2.2 Mice 
 
The strain of LIF knockout mice on a C57BL/6 background was obtained from Dr. David 
Anderson’s laboratory (California Institute of Technology). A polymerase chain reaction 
(PCR)-based method was used to determine the genotype of the mice. Genomic DNA 
was isolated from ear biopsies. These biopsies were digested over night at 37°C using 
DNA lysis buffer (100 mM Tris-HCl [pH 8.1], containing 0.2% SDS, 200mM NaCl, 
5mM EDTA, 10mg/ml proteinase K). DNA was precipitated with 100% ethanol, and 
dissolved in 200 μl TE buffer.  100-150 ng was subjected to PCR amplification (5 min at 
95°C, hold at 4°C; 38 cycles of 30 s at 95°C, 45 s at 63°C, 45 s at 72°C; and 10 min at 
72°C, then hold at 4°C). The reaction mixture contained 1× PCR buffer (10 mM Tris–
HCl [pH 8.3], 50 mM KCl), 3.0 mM MgCl2, 0.1 mM dNTPs, 0.1 U/μl Taq-polymerase 
and 0.4 pmol/μl primers (each) in a total volume of 50 μl. Two specific DNA fragments 
were co-amplified: a 192-bp LIF gene fragment (using a LIF sense primer, 5′-
cgcctaacatgacagacttcccat-3′, and a LIF antisense primer, 5′-aggcccctcatgacgtctatagta-3′) 
and a 541-bp neomycin gene fragment (using a Neo-sense aggcccctcatgacgtctatagta-3′) 
and a 541-bp neomycin gene fragment (using a Neo-sense primer, 5′-
ccagctcttcagcaatatcacggg-3′, and a Neo-antisense primer, 5′-cctgtccggtgccctgaatgaact-3′). 
LIF WT mice contained only the LIF product (192 bp); the heterozygotes had both bands 
(192 and 541 bp); and the LIF-deficient mice had only the larger fragment (541 bp). 
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2.3 Expression vectors and adenovirus constructions 
 
Mouse neurogenin2 (Ngn2) was amplified via PCR (5 min at 95°C, hold at 4°C; 35 
cycles of 40 s at 94°C, 60 s at 53°C, 60 s at 72°C; and 10 min at 72°C, then hold at 4°C). 
The reaction mixture contained 1× PCR buffer (10 mM Tris–HCl [pH 8.3], 50 mM KCl), 
3.0 mM MgCl2, 0.1 mM dNTPs, 0.1 U/μl Taq-polymerase and 0.4 pmol/μl primers (each) 
in a total volume of 50 μl using the following primers: Ngn2 sense primer, 5’-
cgggatccgccgccatgttcgtcaaatctg-3’; Ngn2 antisense primer, 5’-
ggaattcctagatacagtccctggcg-3’. The PCR fragment was then cloned into a TOPO-TA-
vector (TOPO TA Cloning System; Invitrogen) following the manufacturer’s protocol, 
then cut and ligated (Quick Ligation Kit, NEB) into the BamH1/EcoR1 sites of an 
adenoviral shuttle vector, pMZL6, containing a GFP expression cassette. Transformation 
into DH5α competent cells was performed using standard protocols, while mini-prep 
(Promega), and maxi-prep (Invitrogen) were performed following the instructions of the 
manufacturer’s protocol. 
The mouse Mash1 construct was obtained from Dr. David Anderson’s laboratory 
(California Institute of Technology) and cloned into the EcoR1 site of pMZL6.  
Myc-tagged Neurogenin1 was also cloned into EcoR1 sites of pMZL6 and has been 
described previously (Sun et al., 2001).  
Recombinant adenoviruses of Ngn1,  Ngn2 and Mash1 were made by co-transfection 
(Lipofectamin 2000; Invitrogen) of the shuttle plasmids with the plasmid pBHG10 into 
HEK293 cells. Viruses were amplified by infecting HEK293 cells, followed by the 
harvesting of the virus-containing supernatant after about 2-3 days. Supernatant was then   27
tittered and frozen at -80°C. 4 hours after infection with adenovirus, cell medium was 
usually changed to DMEM /N2 minimal medium, and cells were treated with LIF. 
 
 
2.4 PLCγ and PKCδ siRNA 
 
PLCγ and PKCδ siRNA duplex were obtained from IDT DNA Technologies. The 
following duplex sequences were used: PLCγ sense: 5’-uaaagcuacaggacaaugutt-3’, PLCγ 
antisense: 5-acauuguccuguagcuuuatt-3’. 
The duplex-siRNA was then transfected via electroporation using The Nucleofector 
Device (Amaxa Biosystems), the siRNA Test Kit (Amaxa Biosystems), following the 
manufacturer’s protocol. Cells were co-transfected with a pmaxGFP vector as a 
transfection control. 
 
 
2.5 Immunocytochemistry 
 
Cell cultures were routinely fixed for 3 minutes with methanol/acetone (vol/vol 1:1) or 20 
minutes with 4% paraformaldehyde at room temperature (20-25°C). After 3 times 
washing with 1×PBS, cells were permeablized in 1×PBS containing 0.04% Triton X-100 
at room temperature for 30 minutes to 1 hour. For staining, the fixed and permeablized 
cells were incubated in a blocking buffer, Tris-buffered saline (TBS) with 0.02% Tween-
20 plus 10% milk and 1% normal goat serum, at room temperature for 1 hour. Primary   28
antibodies were diluted with a dilution buffer (TBS with 0.02% Tween-20 plus 3% 
bovine serum albumin [BSA]) and added to the cells after incubation with blocking 
buffer. Cells were usually incubated with primary antibodies at 4°C overnight and were 
washed 3 times with 1×PBS before incubating with Cy2- or Cy3-conjugated secondary 
antibodies (Jackson Immunoresearch). This incubation was performed at room 
temperature for 1-2 hours in dark. After the final 3 times 1×PBS washes, coverslips were 
mounted onto glass slides with a mounting solution containing an antifluorescent 
bleaching reagent, n-propyl-gallate (5% in PBS:glycerol, 1:1). 
Neurons were labaled with mouse monoclonal anti-neuronal specific βIII tubulin (TuJ1) 
(Babco/Covance, 1: 500 dilution), while astrocytes were labeld with mouse monoclonal 
anti-GFAP antibody (Sigma, 1:400 dilution).  
Images were taken with an Olympus fluorescent microscope. 
 
 
2.6 Immunohistochemistry 
 
The embryonic (E13) brains from LIF knockout, heterocygote and wildtype mice were 
removed from the skull, fixed in 4% paraformaldehyde (PFA) in PBS overnight at 4°C. 
All brains were cryoprotected with 20% sucrose for 24 hours, embedded in O.C.T., 
frozen liquid nitrogen, cut in the coronal plane on a cryostat at 10 μm, and then mounted 
onto Superfrost (plus) slides. Slides were then stored at -80°C. For tissue staining, the 
brain slides were removed from the –80°C freezer followed by a 30 min equilibration to 
room temperature. Afterwards, the slides were rinsed three times  (10 min each time) on a   29
shaker in 0.1M PBS. For post-fixation, the slides were incubated in 4% PFA followed by 
three 10 min washes in 0.1 PBS. Next, the brain slides were removed from the staining 
dishes, the PBS drained with vacuum, and then placed in a staining tray that contained 
wet paper towels that kept the chamber humidified. As a blocking step, slides were 
covered with about 200 μl blocking solution (3% normal donkey serum in 0.1M PBS) for 
1 hour at room temperature. After blocking the tissue slides, the blocking solution was 
removed and the primary antibody cocktail (mouse monoclonal anti-neuronal specific 
βIII tubulin (TuJ1), Babco/Covance,1:500; PSA-NCAM, Chemicon, 1:500 in blocking 
solution) was applied, and slides incubated over night at 4°C.  
The following day, the slides were washed three times for 10 min in 0.1M PBS on a 
shaker, then removed from the staining dish, PBS carefully removed with a vacuum, 
slides placed in black staining tray, and covered with the secondary antibody cocktail 
(Cy3-conjugated secondary antibodies (Jackson Immunoresearch) at a 1:200 dilution in 
blocking buffer) for 1 hour at room temperature. After the secondary antibody exposure, 
the slides were washed three times for 10 min with 0.1M PBS on a shaker. Next, slides 
were removed from PBS, the excess PBS drained with a paper towel, two drops of 
Vectashield (Vector Labs) applied, and then coverslips placed on top of them. Slides 
were then dried for about 1 hour at room temperature, and then stored at 4°C. Images 
were captured with an Olympus fluorescent microscope. 
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2.7 Western-blot analysis and immunoprecipitation 
 
When cells were confluent adenoviruses were added for about 4 hours. Afterwards the 
medium was changed from DMEM/B27 to DMEM/N2 minimal medium and cells were 
treated with LIF and certain cell signaling inhibitors (Calphostin C, Calbiochem, 300 nM; 
Ro-32-0432, Calbiochem, 1 μM; Rottlerin, Calbiochem, 3 μM; PD 98059, Calbiochem, 
10 μM; LY 294002, Calbiochem, 50 μM). Cells were rinsed in 1×PBS, lysed in 0.7% 
NP40 lysis buffer (50 mM Tris-HCl [pH 8.0], 0.1 mM EDTA [pH 8.0], 250mM NaCl, 
10% glycerol, 0.2 mM Na3Vo4, 50 mM NaF, 1 mM PMSF, 10 mM DTT, and a cocktail 
of protease inhibitors (Roche Applied Science)) and centrifuged at 13,000 rpm for 15 min 
at 4°C. After the determination of protein concentration (Bio-Rad), the resulting 
supernatants were size-separated by 10% SDS-PAGE and transferred to nitrocellulose 
membranes (Bio-Rad). Western blotting was performed using standard protocols.  
For immunoprecipitation cells grown on a 6-well plate were lysed in 150 μl 0.5% NP40 
lysis buffer, centrifuged at 13,000 rpm for 15 min at 4°C, and pre-cleared with 30 μl 
protein A agarose beads (Upstate) (in IP lysis buffer (1:1 ratio)) for 1 hour at 4°C. After 
adjustment of protein concentration and saving of about 25 μl protein sample as a control, 
about 1 μg antibody was added to each sample, which a was then rocked over night at 
4°C. The next day, 30 μl protein A agarose beads were added and the samples rocked for 
one further hour at 4°C. The beads were then washed three times with 500 μl IP lysis 
buffer, and the samples boiled for 5 min after 80 μl IP buffer and 20 μl 5x protein loading 
buffer was added. Proteins were separated on a 10% SDS-PAGE.    31
The antibodies used for western-blot analyses were the following: mouse monoclonal 
anti-GFAP (Sigma), mouse monoclonal anti-neuronal specific βIII tubulin (TuJ1) 
(Babco/Covance), rabbit anti-neurogenin-1 (gift from Dr. Jane E. Johnson, University of 
Texas Southwestern), rabbit anti-neurogenin-2 (gift from Dr. David J. Anderson, 
California Institute of Technology), rabbit anti-CBP (Santa Cruz Biotechnology), rabbit 
anti-Akt (Cell Signaling Technology), rabbit anti-phospho-Akt (Cell Signaling 
Technology), rabbit anti-p42 MAPK (Cell Signaling Technology), rabbit anti-phospho-
p44/p42 MAPK (Cell Signaling Technology), rabbit anti-PKC (Cell Signaling 
Technology), rabbit anti-phospho-PKC (pan) (Cell Signaling Technology), mouse 
monoclonal anti-MAP2 (Sigma), rabbit anti-Brg1 (gift from Dr. Weidong Wong, 
National Institutes of Health), mouse anti-Myc (Santa Cruz Biotechnology), rabbit anti-
Phospholipase C gamma (Upstate),  mouse monoclonal anti-GAPDH (Abcam).  
Secondary goat anti-mouse or anti-rabbit IgG-horseradish peroxidase conjugated 
anibodies (CalBiochem) were used, and detection was performed using the ECL plus 
chemiluminescense (PerkinElmer) on X-Omat Blue films (Kodak).  
 
 
 
2.8 Dual luciferase reporter assay 
 
The NeuroD, NeuroD E-box mutant and GFAP promoter-luciferase reporter constructs 
(NeuroD-pGL3; NeuroD E-box-mut-pGL3, GFAP-pGL3) have been previously 
described, as has the Ngn1-pcDNA3 (Invitrogene) construct (Sun et al., 2001; Bonni et 
al., 1997). Mash1 and Ngn2 plasmid-constructs were described above.    32
To study the promoter activity, neural progenitor cells were plated onto PO/FN-coated 96 
well plates at a density of 5 million cells per plate. Transient transfection into neural 
porgenitor cells was performed using FuGENE-6 reagent (Roche) in accordance with the 
manufacturer’s instructions. The TK-pRL Renilla luciferase constructs (Promega) were 
used as transfection controls in the dual luciferase assays. 4 hours after Ngn1-pcDNA3/ 
control-pcDNA3, or Ngn2-pMZL6/control-pMZL6, or Mash1-pMZL6/conrol-pMZL6 
plasmids were co-transfected with TK-pRL Renilla constructs into neural progenitor 
cells, cell medium was changed to DMEM/N2 minimal medium, cells were treated with 
LIF (100ng/ml) and then lysed after further 24 hours incubation. Luciferase assays were 
performed using the dual-luciferase reporter system (Promega). The results shown 
indicate luciferase activities normalized against an internal luciferase reporter of Renilla 
luciferase (Promega).  
Statistical analyses were carried out using Microsoft Excel. 
 
 
2.9 Chromatin Immunoprecipitation assays 
 
Day 1: 
Cultured neural progenitor cells were harvested using a modified protocol from Upstate 
Biotechnologies. Cells were grown on 10cm dishes, and, when dense, infected with 
Ngn1- or control-Adenovirus. About 4 hours after, medium was changed and cells were 
treated with LIF (100ng/ml). Next, medium was removed, and after two washes with 
iced-cold PBS cells were cross-linked with 1% formaldehyde in 1×PBS for 15 min at   33
room temperature. After two washes with iced-cold PBS, cells were scraped into a 15ml 
tube on ice, harvested by centrifugation (2000 rpm, 5 min, 4°C), and lysed with 0.3 ml 
SDS lysis buffer (1g/ml) containing protease inhibitor cocktails (Roche) and 1 mM DTT 
for about 10 min on ice. Lysates were were sonicated at 4°C using a microtip (Branson 
sonifier 450) to generate DNA fragments 200-1000 base pairs in length. Then the cell 
lysate was transferred to a new eppendorf tube and centrifuged for 10 min at 13,200 rpm 
at 4°C. Equal amounts (35 μg DNA by OD 260 nm reading) of chromatin were diluted in 
100μl SDS lysis buffer containing 10% glycerol. 5% of lysate per IP was saved for an 
input control. As a next step, chromatin was diluted to 1 ml with ChIP dilution buffer, 
and then pre-cleared with 30 μl protein A agarose beads (Upstate) for 1 hour at 4°C. 
Immunoprecipitation was performed over night (for about 15 hours) at 4°C with 2-3 μg 
antibodies.   Immunoprecipitation with normal mouse or rabbit IgG (Santa Cruz) was 
used as a negative control.  
 
Day2: 
Immunoprecipitated DNA/protein complexes were collected by adding 40 μl protein A 
agarose beads (rotation for 1 hour, at 4°C), and centrifuged at 1000 rpm for 1 min at 4°C. 
After the supernatant was carefully removed, beads were washed with 1ml under rotation 
for 5 min at 4°C with low salt, high salt, LiCl, and TE buffer. Next, 120 μl freshly 
prepared elution buffer (ddH2O containing 1% SDS, 0.1M NaHCO3) was added to the 
beads, briefly vortexed, rotated for 15 min at room temperature, and then centrifuged at 
1000 rpm for 1 min. 100 μl were transferred to a new 1.5 ml tube, and the previous step   34
repeated (200 μl total). 8 μl of 5M NaCl were then added to the 200 μl total eluate. To 
reverse the cross-link the DNA/protein complex was incubated at 65°C for at least 6 
hours to over night. Included were also the saved input samples, which were diluted to 
200 μl total volume with elution buffer. 
 
Day 3: 
To each sample (200 μl) 4 μl EDTA (0.5M), 8 μl Tris-HCl (1M, pH 6.5) and 1 μl 
proteinase K was added, followed by incubation at 37°C for 1-2 hours. To purify the 
DNA, 220 μl phenol was added, the samples vortexed for about 10 sec, and then 
centrifuged at 13,200 rpm for 10 min at room temperature. The upper aqueous phase was 
then transferred to a new tube, and 200 μl chloroform was added. The samples were 
vortexed again for about 10 sec, and then centrifuged at 13,200 rpm for 10 min at room 
temperature. The upper phase was transferred to a new tube. To precipitate the purified 
DNA (200 μl), 20 μl 3M NaOAc (0.1 Vol.), then 1 μl glycogen (20 μg/μl), and then 500 
μl 100% EtOH (2.5 Vol.) was given to each sample, followed by incubation for 1 hour at 
-80°C. Samples were then centrifuged for at 13,200 rpm for 10 min at 4°C. The DNA 
pellet was washed with 1 ml 70% cold EtOH, air-dried, and then dissolved in 50 μl TE 
buffer. 2.5 to 5 μl of the IP DNA was then used for each semi-quantitative hot-start PCR 
reaction (5 min at 95°C, hold at 4°C; 35 cycles of 45 s at 95°C, 45 s at 54°C, 45 s at 
72°C; and 10 min at 72°C, then hold at 4°C) using primers designed to amplify DNA 
within the NeuroD promoter region.    35
The reaction mixture contained 1× PCR buffer (10 mM Tris–HCl [pH 8.3], 50 mM KCl), 
3.0 mM MgCl2, 0.1 mM dNTPs, 0.1 U/μl Taq-polymerase and 0.4 pmol/μl primers (each) 
in a total volume of 50 μl using the following primers: NeuroD sense primer: 5’-
ccccagatgtcctctgtctt-3’; NeuroD antisense primer: 5’-gaaccacgtgacctgcctat-3’. 
Antibodies used for the chromatin immunoprecipitation were rabbit anti-neurogenin-1 
(gift from Dr. Jane E. Johnson, University of Texas Southwestern), rabbit anti-CBP 
(Santa Cruz Biotechnology), and mouse anti-Brg1 (gift from Dr. Weidong Wong, 
National Institutes of Health).  
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3.1 LIF enhances Neurogenin’s transcriptional activation in cortical 
NPCs 
 
In the cerebral cortex Ngn1 and Ngn2 are detected exclusively in the ventricular 
zone, where precursor cells reside, and only during the period of cortical neurogenesis 
(Guillemont and Joyner, 1993; Lo et al., 1991; Sommer et al., 1996). While Ngn1 and 
Ngn2 are expressed in the dorsal telencephalon, which gives rise to glutamatergic 
neurons, Mash1 is predominantly expressed in the ventral telencephalon, which gives rise 
to GABAergic and cholinergic neurons (Wilson and Rubinstein, 2000). As previously 
shown, Ngn1 promotes neurogenesis by binding as a transcriptional complex together 
with CBP/p300 to the NeuroD promoter (Sun et al., 2001). However, the programs of 
gene expression that are mediated by Mash1 activity in the ventral telencephalon are still 
unknown.  
To examine whether LIF can enhance the neurogenic effect of Ngn1, Ngn2 and 
Mash1 on a transcriptional level, neural progenitor cells (NPCs) from mouse E11 cortices 
were co-transfected with a NeuroD promoter-luciferase reporter and Ngn1,  Ngn2, or 
Mash1 expression constructs. Coexpression of Ngn1 and Ngn2 significantly enhanced 
NeuroD promoter activity, while LIF even further enhanced this effect (Figure 1A). On 
the other hand, Mash1 expression did not lead to any NeuroD promoter activity in 
cortical NPCs whether cells were treated with LIF or not (Figure 1A). 
Since the induction of NeuroD transcription could have been due to a positive 
feedback of NeuroD binding to its own promoter and therefore further enhancing its own 
expression, NPCs were also co-transfected with a NeuroD-expressing plasmid and the   38
NeuroD promoter-luciferase reporter, followed by the treatment with LIF. Compared to 
the effect of LIF and Ngn1 or Ngn2, ectopic expression of NeuoD did not show any 
significant increase in this gene’s own promoter activity, although NeuroD is capable of 
binding to E box elements. The treatment of NeuroD-transfected NPCs with LIF did not 
induce promoter activity either (Figure 1B).  
To examine whether E box binding of Ngn1 to the NeuroD promoter is required 
for the proneural Ngn/LIF effect, NPCs were transfected with Ngn1 and a NeuroD 
promoter-luciferase construct that contained mutations at its E box elements. As shown in 
Figure 1C, E box binding of Ngn1 is very critical for NeuroD transcription, as well as for 
enhanced, LIF induced transcriptional activity of Ngn1.  
The possibility that Ngn1 and Ngn2 instructively promote neural cell fate 
determination implies that both genes induce neurogenesis at the expense of gliogenesis. 
We found that ectopically expressed Ngn1 or Ngn2, but not control, were able to inhibit 
cytokine LIF-induced GFAP promoter activity in cortical precursor cell cultures (Figure 
1D).  
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Figure 1: LIF promotes neurogenesis on the transcriptional level when proneural bHLH factors 
Ngn1 or Ngn2 are expressed. 
(A)  NeuroD luciferase constructs were co-transfected with control,  Ngn1,  Ngn2, or Mash1 expression 
constructs in cortical NPCs, either untreated or treated with LIF for 1 day. (*, P<0.05 compared to control 
group; **, P<0.05 compared to LIF untreated group). (B) Luciferase assay of NeuroD promoter in NPCs 
transfected with Ngn1, Ngn2, or NeuroD. (*, P<0.05 compared to control group; **, P<0.05 compared to 
LIF untreated group). (C) Luciferase activity of NeuroD-E-box-mutant promoter with or without Ngn1 
and/or LIF (D) The 1.9 kb GFAP promoter-luciferase-reporter construct was co-transfected with control, 
Ngn1 or Ngn2 expression constructs into cortical NPCs, either treated or untreated with LIF for 1 day. (*, 
P<0.05compared to LIF treated group).   40
3.2 LIF promotes neurogenesis and inhibits gliogenesis in cortical NPCs 
in the presence of Ngn1 and Ngn2 in vitro 
 
To investigate the effect of Ngn1/Ngn2 and LIF on both the expression of 
neuronal markers such as neuron-specific type III β-tubulin (recognized by the antibody 
TuJ1), and on the expression of astrocyte-specific marker GFAP, an adenoviral vector 
was generated to introduce exogenous Ngn1 or Ngn2 into neural precursor cells cultured 
from mouse E11 cortices. The neural stem cell cultures, because they are homogenous 
and display high (>90%) infection efficiency to adenoviruses, are amenable to gene 
expression studies. When cortical neural precursor cells (NPC) were infected with the 
Ngn1, Ngn2 or control viruses, we found that exogenous Ngn1/2 expression led to a 
significant increase in the number of precursors that became neurons, while treatment 
with LIF even further increased the number of Ngn1/2 infected cells that differentiated 
into neurons (Figure 2A, B, C). To further explore the possibility that Ngn1/2 and LIF 
decrease GFAP expression not only on a transcriptional level, but also on the protein 
level, western analyses were performed. The results revealed that expression of both 
Ngn1 and Ngn2 greatly reduced GFAP expression. As determined by cell counting and 
western blot, LIF had only a minimal positive/promoting effect on GFAP expression 
when proneural Ngn1 and Ngn2 were expressed in NPCs (Figure 2B, D).  
In addition, Ngn1/2-expressing cells displayed a neuronal-like morphology 
(small, round cell bodies with one or two simple processes) that is quite distinct from the 
stellate GFAP-positive astrocytes, suggesting that Ngn1/2 inhibit various aspects of the 
glial differentiation program.    41
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Figure 2: LIF enhances the proneural effect of Ngn1 and Ngn2  Figure 2: LIF enhances the proneural effect of Ngn1 and Ngn2 
(A) Expression of TuJ1 (red) in mouse cortical NPCs infected with adenoviruses containing control/Ngn1-
expression cassettes, and treated with LIF for 24 hours. (B) Quantification of Ngn1/Tuj1 positive cells 
(neuronal) and GFAP (astrocytic) positive cells after infection with control/Ngn1-adenovirus, with or 
without LIF treatment. (C) Western blot analysis showing TuJ1 expression after NPCs were infected with 
Ngn1 or Ngn2 adenoviruses, and treated with LIF. (D) Western blot of E11 mouse cortical NPCs, infected 
with control or Ngn1 gene expression viruses for 24 hours, and treated with bFGF (mitogenic) or LIF. The 
levels of cell type specific markers were determined by using anti-TuJ1 and anti-GFAP antibodies. 
(A) Expression of TuJ1 (red) in mouse cortical NPCs infected with adenoviruses containing control/Ngn1-
expression cassettes, and treated with LIF for 24 hours. (B) Quantification of Ngn1/Tuj1 positive cells 
(neuronal) and GFAP (astrocytic) positive cells after infection with control/Ngn1-adenovirus, with or 
without LIF treatment. (C) Western blot analysis showing TuJ1 expression after NPCs were infected with 
Ngn1 or Ngn2 adenoviruses, and treated with LIF. (D) Western blot of E11 mouse cortical NPCs, infected 
with control or Ngn1 gene expression viruses for 24 hours, and treated with bFGF (mitogenic) or LIF. The 
levels of cell type specific markers were determined by using anti-TuJ1 and anti-GFAP antibodies.   42
3.3 Potential signaling pathways mediating the neurogenic effect of LIF 
 
LIF is a member of the family of interleukin-6 type cytokines, which have 
overlapping, pleiotropic effects on a variety of different cell types and activate target 
genes involved in survival, apoptosis, proliferation and differentiation, as well as 
suppression of differentiation (Heinrich P. C., 2003). LIF binds directly to the low-
affinity LIF receptor β (LIFRβ) that subsequently heterodimerizes with the signal 
transducer glycoprotein 130 (gp130). The formation of this high-affinity trimeric 
complex composed of two class I cytokine receptors, LIFRβ and gp130, and LIF leads to 
the activation of several downstream pathways essential for regulating biological 
responses: the JAK-STAT, the MAPK, the Akt/PI3K, and the PLCγ/PKC pathways 
(Figure 3; Kristensen et al., 2005). However, since it has already been shown that a LIF 
activated JAK-STAT pathway promotes glial cell differentiation in late NPC, we 
investigated the effects of the latter three signaling pathways with regards to pathway 
activation and correlation to neurogenesis.  
As shown by David Turner’s lab (Vojtek et al., 2003), endogenous Akt kinase 
plays an essential role in neurogenesis in mouse P19 teratocarcinoma cells not only by 
promoting neuronal survival, but also by enhancing the complex formation of CBP/p300 
with ectopically expressed Ngn3. In addition, inhibition of the Akt/PI3K pathway 
abolished this complex formation.  
The MAPK pathway is important to keep fetal NSCs and ES cell derived NSCs 
in a proliferative state, with growth factors, such as bFGF, EGF, IGF I, II, and III being 
important activators of this signaling pathway (Colombo et al., 2006). On the other hand,   43
factors such as BDNF and NT-3 can activate MEK and induce neurogenesis by 
mechanisms that are still not well understood (Gosh et al., 1995; Menard et al., 2002). 
Though it was shown in NPCs that activated MEK could activate C/EBP, which directly 
promoted the transcription of at least one early pan-neural gene, Tα1 α-tubulin, a LIF-
induced/MEK-dependent activation of Ngn could not be shown yet (Miller, F; 2005). 
Protein kinase C (PKC) is a family of kinases composed of about 10 different 
isozymes that have been categorized into three groups - the conventional PKCs, the novel 
PKCs and the atypical PKCs - depending on their ligand sensitivities and structural 
properties (Newton et al., 2001; Nakashima et al, 2002; Ohno and Nishizuka, 2002). It 
has been shown that PKCs are involved in diverse cellular processes such as long term 
potentiation in the hippocampal CA1 region, synaptic plasticity, development and 
apoptosis (Malinow et al., 1989; Abbeliovich et al., 1993; Hu et al., 1987; MacDonald et 
al., 1989; Perez et al, 2001; Gutcher et al., 2003). The expression of different PKC 
isoforms varies greatly between tissues, but certain isoforms, for instance PKCα, βII, γ, δ, 
, θ and ζ, are more widely expressed in the CNS (Battaini, 2001).  
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Figure 3: LIF-induced signaling pathways that might promote neurogenesis 
Ngn1 inhibits glia cell differentiation by sequestering CBP/p300 away from glia specific genes. If Ngn1 is 
present, CBP/p300 binds to it and promotes transcription of neuron-specific genes, such as NeuroD, a 
process that is enhanced by LIF through activation of either the Akt/PI3, the MAPK, or the PLCγ/PKC 
signaling pathway. 
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3.4 PLCγ/PKC mediate the effect of LIF on neurogenesis 
 
To address the relationship between LIF and its neurogenic effects, E11, 
(passage 3) NPCs were cotransfected with a NeuroD promoter-luciferase reporter and an 
Ngn1 expression plasmid. About 4 hours after transfection, progenitor cells were treated 
with LIF (100ng/ml) and certain drugs that inhibited the signaling pathways mentioned 
above.  To inhibit the Akt/PI3K pathway we applied LY 294002 (50 μM – Calbiochem), 
for MAPK signaling pathway inhibition PD 98059 (10 μM – Calbiochem), and for PKC 
pathway inhibition a combination of Calphostin C (300 nM – Calbiochem) and Ro-32-
0432 (1 μM – Calbiochem). Using luciferase assays, we observed that the effect of 
Ngn1/LIF on NeuroD promoter activity was diminished by inhibition of all three 
signaling pathways. However, inhibition of the PKC led not only to the strongest 
promoter activity inhibition, but also abolished the pro-neural effect of LIF (Figure 4A).  
Consistent with the luciferase assay results, western blot analyses demonstrated 
a similar outcome on the protein level. The expression of the neuronal-specific marker 
class III β-tubulin/ TuJ1 was diminished by application of all drugs, with PKC inhibitors 
Calphostin C/ Ro-32-0432 leading to the strongest TuJ1 expression inhibition (Figure 4B, 
C). Also, when progenitors where treated with PKC inhibitors, LIF did not cause any pro-
neural effect as it did when cells where treated with Akt/PI3K or MAPK inhibitors.  
Taken together, these results suggest that the pro-neural effect of Ngn and LIF 
in cortical neural progenitors is mediated by the PLCγ/PKC signaling pathway, rather 
than by the Akt/PI3K or MAPK pathways.  
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Figure 4: PKC mediates 
LIF’s pro-neural effect 
(A)  NeuroD luciferase constructs 
were co-transfected with control  or 
Ngn1 expression constructs in cortical 
NPCs, either untreated or treated with 
LIF for 1 day, and PKC       
(Calphostin/RO), Akt (LY), or 
MAPK (PD) pathways inhibited 
using specific drugs. (B) and (C) 
Western blot analyses  of NPCs 
infected with control or Ngn1 
adenoviruses viruses, untreated or 
treated with LIF. Signaling pathways 
were inhibited using specific drugs 
(LY: Akt/PI3K; PD: MAPK; 
Calphostin/RO: PKC). The western 
blot shows protein expression of a 
neural specific marker, TuJ1, with 
regards to activation/ phosphorylation 
and inhibition of certain signaling 
pathway members. pAkt: phospho-
Akt; pMAPK: phospho-MAPK; 
pPKC: phospho-PKC. 
B 
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3.5 PLCγ/PKC promote association between Ngn1, CBP/p300 and Brg1 
 
As previously shown by our lab, Ngn1 competes with STAT3 for CBP/p300 
binding (Sun et al, 2001), which is necessary for transcriptional activity. At later stages of 
cortical development, when progenitor/stem cells give rise to astrocytes, CBP/p300 binds 
to STAT3 to induce glial differentiation, while during earlier development, when 
neurogenesis is at its peak, Ngn sequesters CBP/p300 away from STAT3 and induces 
transcription of proneural genes, such as NeuroD.  
To further explore the mechanism by which LIF enhances NeuroD promoter 
activity, we hypothesized that LIF might enhance Ngn1-CBP/p300 association, leading to 
an increased binding of this complex to the NeuroD promoter. We performed 
coimmunoprecipitation to investigate Ngn1-CBP association in NPCs upon ectopic 
expression of Ngn1 and treatment of cells with LIF. The result shows that LIF 
significantly increases the binding of Ngn1 to CBP (Figure 5A). However, this interaction 
is inhibited by the application of the PKC inhibitors Calphostin C/Ro-32-0432, 
suggesting that LIF promotes association of Ngn1 to CBP via the PLCγ/PKC signaling 
pathway (Figure 5B).  
In addition, we examined Ngn1 association to Brahma-related gene 1 (Brg1). 
Seo et al (2005) previously showed that in Xenopus  Brg1,  a catalytic subunit of the 
SWI/SWF complex, binds to Ngn, and that this cooperation is necessary to induce target 
gene activation during neurogenesis. Therefore, we further hypothesized that Brg1 might 
also associate with the Ngn/CBP cotranscriptional complex in mouse cortical progenitors. 
Coimmunoprecipitation analysis indicated that Brg1 forms indeed a complex with Ngn1   48
and CBP (Figure 5C). To further explore the possibility that LIF promotes Ngn1-Brg1 
association, we treated cells with LIF in the same experiment. The result shows that LIF 
treatment also increased that association, suggesting that Brg1 might also play an 
important role during mouse cortical neuron development (Figure 5C). However, in 
following experiments the focus remained on Ngn and CBP. 
After analyzing the association between Ngn1 and CBP upon LIF treatment, we 
started to analyze the association of this complex to the NeuroD promoter. Cortical NPCs 
were treated with Ngn1 adenovirus and LIF. Chromatin immunoprecipitation (ChIP) 
assays with antibodies against Ngn1 and CBP clearly showed that LIF treatment caused 
an increased binding of the Ngn1-CBP complex to the NeuroD promoter in these cells, 
presumably responsible for the increased transcriptional activation of this gene, and 
therefore also very likely responsible for the increase in neuronal differentiation (Figure 
5D). 
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Figure 5: Association of Ngn1 to CBP and Brg1 is enhanced through LIF induced PKC activation 
(A) Western blot analysis of Ngn1 and CBP in mouse NPCs in the presence of Ngn1 (+/- LIF treatment) 
after immunoprecipitation of CBP. (B) Western blot analysis of Ngn1 and CBP in Ngn1-overexpressing 
progenitors, untreated or treated with LIF, and PKC signaling pathway inhibited using Calphostin C/Ro-32-
0432. (C) Western blot analysis of CBP, Ngn1, and Brg1 after cells were immunoprecipitated with CBP or 
Brg1. NPCs were infected with control or Ngn1 adenoviruses, untreated or treated with LIF for 24 hours.            
(D)  ChIP assay showing that the association of the Ngn1/CBP complex to the NeuroD promoter is 
enhanced by LIF.     50
3.6 PKCδ might be the mediator of LIF in cortical NPCs during 
neurogenesis 
 
Several PKC isoforms are expressed in the developing brain during 
neurogenesis. However, it was shown that in multipotent PCC7-Mz1 embryonic 
carcinoma stem cells retinoic acid (RA) induces neurogenesis while upregulating the 
expression of PKC betaII, delta, epsilon, and eta. The expression of other isoforms 
(alpha, betaI, gamma, theta, mu, lamda and zeta) remained unchanged. In addition, after 
neurogenesis, the expression of PKC betaII, delta and eta decreased again, implying that 
these isoforms might play an essential role during neurogenesis. Of those isoforms, PKC 
delta appeared to be mainly membrane-bound, implying that it was also in an active state 
(Oehrlein et al, 1998). Furthermore, it was shown that RA induces PKC delta (PKCδ) 
expression in NT2 human teratocarcinoma cells, and that this expression is necessary for 
neuronal differentiation (Patel et al, 2006). 
To test our hypothesis that PKCδ might mediate LIF signaling in cortical NPCs, 
we investigated first the expression of this enzyme during mouse cortical development. 
At the peak of mouse neurogenesis, at E14, NPCs expressed the highest level of PKCδ 
(Figure 6A). It increased from E12 to E14, and then decreased again at the end of 
neurogenesis. 
With regards to TuJ1 expression and neuronal differentiation, we next tested a 
PKCδ specific inhibitor, Rottlerin, on NPCs, after cells were infected with Ngn1-
adenovirus, and treated with LIF.  The Figure 6B shows a similar result as that of NPCs 
treated with the general PKC inhibitors Calphostin C/Ro-32-0432. Similar to the general   51
PKC inhibitors, Rottlerin did not allow neuronal differentiation upon Ngn1 infection/LIF 
treatment.  
To investigate the mechanism by which Rottlerin inhibited TuJ1 
expression/neurogenesis, we performed luciferase assays on the NeuroD promoter. NPCs 
were cotransfected with a NeuroD promoter-luciferase reporter and an Ngn1 expression 
plasmid. 4 hours after transfection, progenitor cells were treated with LIF and Rottlerin. 
The result shows that the effect of Ngn1/LIF on NeuroD promoter activity was 
diminished by inhibition of PKCδ. Further, Rottlerin, like Calphostin C/Ro-32-0432, 
abolished the pro-neural effect of LIF (Figure 6C).  
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Figure 6: Inhibition of PKCδ inhibits the pro-neural effect of LIF. 
(A) Western blot analysis of PKCδ in mouse cortices during development - from embryonic day 12 (E12) 
to postnatal day 4 (P4)  - showing highest level of PKCδ at the peak of neurogenesis (at E14). (B) Western 
blot analysis of TuJ1 in NPCs infected with control/Ngn1 adenoviruses, untreated or treated with LIF, +/- 
PKCδ-inhibitor Rottlerin. (C)  NeuroD luciferase constructs were co-transfected with Ngn1 expression 
constructs in cortical NPCs, either untreated or treated with LIF for 1 day, and either PKC       
(Calphostin/RO), or PKCδ  (Rottlerin) pathways inhibited using specific drugs. 
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3.7 PLCγ and PKCδ siRNA abolishes the pro-neural effect of Ngn and 
LIF 
 
There are 10 PKC genes, which code for isozymes classified into three groups: 
Conventional/classical PKCs, novel PKCs and atypical PKCs. Conventional PKCs can be 
activated by calcium and phorbol esters or diacylglycerol (DAG), whereas novel PKCs, a 
group to which PKCδ belongs, can only be activated by phorbol esters or DAG. Atypical 
PKCs are unresponsive to either calcium or DAG. Increases in plasma-membrane DAG 
levels functions for the intracellular relocalization and activation of conventional and 
novel PKCs, occurring in response to receptor tyrosine-kinase stimulation through their 
coupling to PLCγ that then cleaves the lipid phosphoinositide 4,5-biphosphate into the 
soluble second messenger inositol triphosphate and the membrane lipid DAG (Griner et 
al., 2007).  
In order to inhibit conventional/novel PKC as well as PKC delta activity 
without potentially inhibiting the function of other enzymes, we knocked down PLCγ and 
PKCδ expression using duplex RNA interference (RNAi). RNAi is the process of 
sequence-specific, post-transcriptional gene silencing in animals and plants, initiated by 
double-stranded RNA (dsRNA) that is homologous in sequence to the silenced gene 
(Hammond et al., 2001; Sharp et al, 2001). The mediators of sequence-specific 
messenger RNA degradation are 21- and 22-nucleotide small interfering RNAs (siRNAs) 
generated by ribonuclease III cleavage from longer dsRNAs (Elbashir et al, 2001).   
However, it was also shown that 21-nucleotide siRNA duplexes can specifically suppress   54
expression of endogenous and heterologous genes in different mammalian cell lines, 
including HEK293 cells and HeLa cells (Elbashir et al, 2001).  
Neural progenitors (E11, passage 2 [P2]) were first transfected with PLCγ and 
PKCδ siRNA and then, after two days, infected with Ngn adenovirus followed by 
treatment with LIF. Western blot analysis shows downregulation of PLCγ and PKCδ 
expression and, consistent with previous results, also downregulation of the neuronal 
marker TuJ1 (Figure 7A). However, treatment with LIF lead also to an increase in TuJ1 
protein expression in PLCγ or PKCδ-siRNA transfected cells, suggesting that only a 
certain percentage of progenitor cells were transfected with RNAi. To further investigate 
the impact PLCγ and PKCδ siRNA on NPCs, we performed immunocytochemistry on 
cells that were cotransfected with siRNA and GFP, then infected with Ngn1 adenovirus 
and treated with LIF. As shown in Figure 7B, only some progenitors were GFP/RNAi-
positive. Cell counting revealed that only about 30% of NSCs were transfected with 
PLCγ/PKCδ-siRNA. Nevertheless, none of the cells that were GFP/PLCγ-siRNA or 
GFP/PKCδ-siRNA-positive expressed TuJ1 (Figure 7B, C). Even treatment with LIF did 
not lead to any GFP-TuJ1 double-labeled cells, implying again that LIF’s pro-neural 
effect might be mediated by the PLCγ/PKC, or, more specific, by the PLCγ/PKCδ 
signaling pathway. 
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Figure 7: Downregulation of PLCγ or PKCδ using siRNA abolishes LIF’s pro-neural effect 
(A) Western blot analysis of NPCs that were infected with control/Ngn1 adenoviruses, untreated or treated 
with LIF, and transfected with either PLCγ or PKCδ-siRNA shows protein levels of PLCγ and PKCδ with 
regards to TuJ1 expression. (B) Expression studies of TuJ1 (red) in mouse cortical NPCs infected with 
adenoviruses containing Ngn1-expression cassettes, untreated or treated with LIF for 24 hours, in absence 
or presence of PLCγ-siRNA  (C)  or PKCδ-siRNA, does not show TuJ1 protein expression in siRNA 
transfected progenitors.   56
3.8 LIF promotes neurogenesis in vivo 
 
In vivo, extrinsic and intrinsic mechanisms also have a role in the sequential 
generation of neurons and glia cells during development. It has been suggested that LIF, 
synthesized prenatally by neural progenitors, might act in an autocrine/paracrine manner 
promoting astrocyte differentiation. (Chang et al, 2004). Regarding gliogenesis, it has 
been shown that in LIF KO mice cortical gliogenesis seems to occur normally, even 
though adult astrocyte numbers are reduced in some discrete areas such as the 
hippocampus (Barnabe-Heider et al, 2005; Koblar, et al, 1998). In contrast, mice lacking 
gp130 or its co-receptor LIFR exhibited a marked deficit in astrocytes (Koblar et al, 
1998; Ware et al, 1995). It seems, although knocking out individual cytokines does not 
produce a phenotype that is notably different from wild type, blocking the effect of the 
entire cytokine family reveals its important role in gliogenesis in vivo. However, with 
regards to neurogenesis, it has been shown in mice lacking both LIF and CNTF that these 
two factors seem to be primarily responsible for promoting the survival and maintenance 
of developing motor neurons, although deletion of the CNTF gene had more pronounced 
effects than LIF gene deletion on this cell type (Sedtner et al, 1990 and 1996).  
To test the hypothesis that LIF is required for cortical neuron differentiation in 
vivo, we compared the expression of neuronal markers, such as TuJ1, MAP2 and PSA-
NCAM in embryonic day 13 (E13) LIF knock out (KO), heterozygote (Het) and wild 
type (WT) mice. First, we studied the expression pattern of neuron-specific class III β-
tubulin (recognized by antibody TuJ1) on mouse E13 coronal brain sections. This 
antibody has been shown to label postmitotic neurons of the CNS very early, during or   57
immediately after the last mitotic cycle (Lee at al, 1990). However, as shown in Figure 
8A, no major differences between WT, Het and KO mice could be observed, although it 
seemed that TuJ1 was slightly less expressed in the pre-plate of Het and KO mice 
compared to that of WT mice. To further investigate neuronal differentiation we labeled 
E13 cortical neurons with an additional neuron-specific marker, PSA-NCAM. The anti-
PSA-NCAM antibody recognizes polysialic acid (PSA), which, in vertebrates, is linked 
to the extracellular domain of the neural cell adhesion molecule (NCAM). PSA-NCAM, 
the highly polysialated form of NCAM, is predominantly expressed in embryonic and 
neonatal neural tissue and is a marker for immature neuronal-committed progenitors. 
Staining neurons with anti-PSA-NCAM did not reveal major phenotype differences 
either. However, similar to TuJ1 staining, PSA-NCAM expression seemed to be slightly 
diminished in Het and KO mice when compared to WT mice (Figure 8B). 
In order to gain more quantitative results, we applied western blot analysis 
investigating expression of TuJ1 and microtubule-associated protein 2 (MAP2) in mouse 
E13 cortices. Our data show that cortical TuJ1 expression was significantly decreased in 
LIF Het and KO mice compared to LIF WT mice, indicating that LIF might promote 
neuronal differentiation not only in vitro, but also in vivo (Figure 8C). Further labeling 
with an anti-MAP2 antibody supported this idea. The antibody recognizes MAP2-
isoforms MAP2a, MAP2b and MAP2c. While MAP2c is predominantly found in 
growing dendrites of immature neurons, the isoforms MAP2a and MAP2b are expressed 
in dendrites of mature neurons (Belanger et al, 2001). As shown in figure 8C, E13 LIF 
Het and KO mice display less MAP2a/b than WT mice, suggesting that, during cortical 
development, LIF might be an important factor promoting neuronal maturity.   58
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
B 
C  Figure 8: LIF promotes expression of pro-neural markers 
in vivo 
(A) and (B) Immunohistochemistry of mouse E13 LIF WT, 
Het and KO coronal brain sections. Tissues were stained with 
pro-neural markers for TuJ1 and PSA-NCAM. (C) Western 
blot analysis of mouse E13 LIF WT, Het and KO cortices 
showing a decrease of the neuronal markers TuJ1 and MAP2 
a/b in Het and KO mice compared to WT mice, while Ngn1 
and Ngn2 levels remained the same.                              
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3.9 LIF heterozyogte and knock out mice display less binding of the 
Ngn1-CBP cotranscriptional complex to the NeuroD promoter 
 
After analyzing the association of the Ngn1-CBP cotranscriptional complex to the 
NeuroD promoter in vitro in previous experiments, we started to analyze the association 
of this complex to the NeuroD promoter in vivo (cortical tissues), comparing E13 LIF Het 
and KO mice to WT mice. Chromatin immunoprecipitation (ChIP) assays with antibodies 
against Ngn1 and CBP revealed that LIF Het and KO mice display less binding of the 
Ngn1-CBP complex to the NeuroD promoter, presumably responsible for a decreased 
transcriptional activation of this gene, and therefore also very likely responsible for the 
decrease of neuron-specific markers such as MAP2a/b and TuJ1 (Figure 9). 
 
 
Figure 9: Association of the Ngn1-CBP cotranscriptional complex to the NeuroD promoter is 
enhanced by LIF in vivo 
ChIP assay showing the association of the Ngn1/CBP complex to the NeuroD promoter in vivo. Cortices of 
E13 LIF Het and KO mice were isolated and compared to WT mice. 
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Discussion 
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The development of the mammalian CNS, including the cerebral cortex, is a 
temporally and spatially well-organized process. Previous studies have shown that during 
cortical development, the neurogenic machinery is largely composed of a cascade of 
transcriptional activation events mediated by neurogenic bHLH factors. Subsequent steps 
in the differentiation process are mediated by successive waves of neuronal bHLH 
differentiation genes. Neurogenesis is therefore mediated by two broad categories of 
bHLH factors, pro-neural bHLH factors (e.g, Ngn1 and Ngn2), which are involved in 
initiating neurogenesis, and neuronal differentiation bHLH factors (e.g., NeuroD), which 
are involved in mediating terminal differentiation.  
Our studies suggest a novel function of cytokine LIF during cortical 
development. We demonstrated that LIF, a factor that is well-known for promoting 
gliogenesis, also promotes neurogenesis in vitro and in vivo. Our in vitro data showed 
that LIF, through activation of the PLCγ/PKC signaling pathway, and probably through 
activation of PKCδ, enhanced the association of ectopically expressed Ngn with CBP, 
leading to an increased association of this transcriptional complex to the NeuroD 
promoter. Also, LIF seemed to increase the binding of Ngn to Brg1, a factor, which might 
also be important for enhanced NeuroD transcription. However, increased NeuroD 
transcriptional activation, in turn, led to increased expression of neuron-specific markers 
such as neuron-specific class III β-tubulin. In addition, our in vivo data demonstrate that, 
compared to wildtype (WT) mice, LIF knock-out (KO) and LIF heterozygote (Het) mice 
display less mature neurons, as suggested by a decrease of neuron-specific markers 
MAP2a/b as well as class III β-tubulin, presumably caused by a decreased association of 
Ngn1-CBP to the NeuroD promoter.   62
4.1 Novel pro-neurogenic role of LIF during cortical neurogenesis is 
solely dependent on the expression of bHLH factors Ngn1 and Ngn2  
 
LIF has been known for some time to have the role in determining cell 
phenotype, and was originally characterized in the nervous system for its ability to induce 
a switch from noradrenergic to cholinergic phenotype in cultured sympathetic neurons 
(Yamamori et al., 1989). LIF and CNTF induce premature generation of astrocytes in 
vitro through activation of the JAK-STAT and MAPK pathways (Bonni et al., 1997; 
Chang et al., 2004). Interestingly, LIF mediates astrogliogenesis in late (>E15), but not in 
early (E12-E14), cortical progenitors in mice (Chang et al., 2004; Barnabe-Heider et al., 
2005). We showed that this might be due to a developmental increase of Ngn1/2 during 
cortical neurogenesis. As previously shown, Ngn not only promotes neurogenesis, but 
also inhibits gliogenesis (Sun et al., 2001). Also, it was shown that cortical expression of 
Ngn1/2 is positively regulated by factors such as Pax6, while, on the other hand, the 
action of Ngns is negatively regulated by Id bHLH factors, which bind to E-proteins and 
thereby inhibit the activity of pro-neural bHLH factors, including Ngn1 and Ngn2, that 
require E-proteins for their activity (Toresson et al., 2000; Norton, 2000). However, the 
signaling pathways and mechanisms that positively regulate the activity of pro-neural 
factors  Ngn1/2 are still unknown. Our results suggest a novel function of LIF by 
promoting neuronal differentiation in cortical NPCs, but only during neurogenesis, when 
Ngn is expressed. 
It has previously been shown by our lab that Ngn inhibits glial differentiation 
via several mechanisms. First, it inhibits STAT1/3 phosphorylation via a DNA-binding   63
independent, still unknown mechanism, which is not enhanced by LIF (Sun et al, 2001).  
Second, Ngn sequesters CBP/p300 away from STAT1/3, a process that is, as our work 
shows, enhanced by LIF. However, since through this action LIF diminishes the CBP 
pool available for STAT-binding, which is necessary to induce glial gene activation, LIF 
can even be considered as an inhibitor of glial differentiation during cortical neurogenesis 
and Ngn expression. Third, as recently shown by our lab, Ngns might suppress alternative 
cell fates through directly turning on the expression of microRNAs (such as miR-9) by 
binding to E-box elements in the promoter region of such microRNAs (He et al., 
unpublished data). In turn, these microRNAs negatively regulate the signaling molecules 
(like gp130) of the JAK-STAT pathway by binding to the 3’UTR of its target mRNAs. 
Since binding of the Ngn/CBP-transcriptional complex to the NeuroD-promoter is 
enhanced by LIF, it is be intriguing to speculate that binding of this complex to promoter 
regions of certain microRNAs is enhanced by LIF as well. Through posttranscriptional 
downregulation of, for example, gp130, LIF might thereby negatively trigger its own pro-
neural action during neurogenesis.  
 
 
4.2 LIF promotes CBP-Ngn1 association, leading to enhanced NeuroD 
transcription and therefore to increased neurogenesis 
 
The pro-neural bHLH factor Ngn interacts with coactivators CBP as well as 
p300, which facilitate the assembly of active transcription factor complexes in part by 
bringing transcription factors and basal components of the transcriptional machinery into   64
proximity, as well as by acetylation of histones and transcription factors through an 
intrinsic acetyltransferase activity (Sun et al., 2001; Eckner et al., 1996; Koyano-
Nakagawa et al., 1999; Goodman et al., 2000). Our data indicate that LIF-induction 
increases transcriptional activation of ectopically expressed Ngn1/2. Furthermore, LIF 
could increase the amount of Ngn1 (and possibly Ngn2) that is associated with CBP, 
providing a likely mechanism for the increased transcriptional activity. The possibility 
that increased Ngn1-CBP association is caused by increased LIF-induced Ngn1 
expression can be ruled out, since our data demonstrate that Ngn1 levels remained 
unchanged. However, increased NeuroD  expression, which is necessary for terminal 
neuronal differentiation, led in turn to an increase in generation neurons, as shown by the 
expression of class III β-tubulin, which is recognized by the antibody TuJ1.  This 
antibody has been show to label postmitotic, immature/mature neurons of the CNS very 
early, during or immediately after the last mitotic cycle (Lee et al., 1990). Thus it seems 
that LIF plays an important role in initiating terminal neuronal differentiation, rather than 
in initiating neurogenesis. 
The fact that ectopically expressed Ngn reflects the function of endogenous Ngn 
is supported by previous findings that show that, first, endogenous Ngn sequesters CBP 
away from STATs in extracts from E14 cortices, where Ngn is expressed at physiological 
levels, second, during cortical development, gliogenesis does not begin before Ngn levels 
fall and CBP becomes available for STAT-binding, and third, knock-out of Ngn results in 
inhibition of neurogenesis and increased glial differentiation (Sun et al., 2001; Nieto et 
al., 2001; Tomita et al., 2000).  
   65
4.3 LIF-induced PKC activity is necessary for CBP-Ngn association 
 
 LIF is a member of the family of interleukin-6 type cytokines, which have 
overlapping, pleiotropic effects on a variety of different cell types and activate target 
genes involved in survival, apoptosis, proliferation and differentiation, as well as 
suppression of differentiation (Heinrich P. C., 2003). LIF binds directly to the low-
affinity LIF receptor β (LIFRβ) that subsequently heterodimerizes with the signal 
transducer glycoprotein 130 (gp130). The formation of this high-affinity trimeric 
complex composed of two class I cytokine receptors, LIFRβ and gp130, and LIF leads to 
the activation of several downstream pathways essential for regulating biological 
responses: the JAK-STAT, the MAPK, the Akt/PI3K, and the PLCγ/PKC pathways 
(Kristensen et al., 2005).  
Here we showed that, during neurogenesis, PKC is required for the pro-neural 
LIF effect in mouse cortical NPCs, in which Ngn was ectopically expressed. First, we 
demonstrated that pharmacological inhibitors of MAPK, Akt/PI3K, and PKC displayed 
the strongest inhibition of neuronal differentiation when PKC inhibitors were applied. 
Not only was NeuroD transcription inhibited by PKC inhibition, but also the pro-neural 
LIF effect abolished. This was not the case when applying drugs against MAPK and 
Akt/PI3K, suggesting that the pro-neural effect of LIF might be mediated by PKC. In 
addition, protein expression of the neuronal marker class III β-tubulin was most 
diminished upon administration of PKC inhibitors, where LIF treatment did not cause, as 
expected, a further increase of this marker either. It might therefore be of interest to 
further investigate possible Ngn and/or CBP consensus sites that can get potentially   66
phosphorylated by PKC during neurogenesis, and maybe even show that mutation of 
these sites abolishes LIF’s pro-neural function. 
As previously shown, MAPK and Akt/PI3K signaling pathways are important 
for mouse cortical neurogenesis and survival, respectively. Although it was shown by 
David Turner’s lab (Vojtek et al., 2003) that beside being involved in neuronal survival, 
Akt1 and Akt2 promote neuronal differentiation in mouse P19 teratocarcinoma cells by 
activating ectopically expressed Ngn3, the targeted disruption of either Akt1 or Akt2 in 
mice had no apparent effect on neuron formation or differentiation, reflecting differences 
between P19 cells and neural progenitors on the level of Akt signaling (Chen et al., 2001; 
Cho et al., 2001a; Cho et al., 2001b). Regarding MAPK signaling, Paquin et al. (2005) 
showed that MEK-induced C/EBP phosphorylation/activation is essential for cortical 
neurogenesis in vivo, proposing that activated C/EBP might collaborate with pro-
neuronal bHLH factors to ultimately promote neurogenesis by activating transcription of 
neuron-specific genes such as Tα1 α-tubulin. However, this group did not provide any 
evidence showing how MEK could activate, or partially activate any bHLH factors, or, 
more specifically, activate Ngn.  
Our work indicates that PKC might be the mediator of LIF’s pro-neural effect in 
cortical NPCs. We also showed that PKCδ, a PKC isoform, is upregulated during 
neurogenesis, and downregulated again during gliogenesis, implying a potentially 
important role during neuronal differentiation. Oehrlein et al. (1998) previously showed 
that PKCδ is upregulated during neurogenesis in mouse PZZ-7 Mz1 embryonic 
carcinoma cells, where neuronal differentiation was induced by retinoic acid. In addition, 
the same group showed that growth-associated protein 43 (GAP-43), which has an   67
important function in regulating the growth state of axon terminals, and was described as 
a postmitotic, neuron-specific PKC substrate, is actually already expressed in rat 
forebrain NPCs during neurogenesis, supporting the idea for the role of PKC during 
cortical neuronal development (Esdar et al., 1999, Burry, 1998). In transgenic mice, 
overexpression of GAP-43 led to spontaneous formation of new synapses and enhanced 
sprouting after injury. GAP-43 appears to be involved in transducing intra- and extra-
cellular signals to regulate cytoskeletal organization in nerve endings. Phosphorylation by 
protein kinase C is particularly significant in this regard, and is linked with both nerve-
terminal sprouting and long-term potentiation.  
When we infected NPCs with Ngn adenovirus and stimulated them with LIF, 
inhibition of PLCγ expression using siRNA led to inhibition of class III β-tubulin 
expression in the same way as inhibition of PKCδ expression did. This suggests that 
PKCδ might be a very likely mediator of the pro-neuronal LIF effect. Among the PKC 
isoforms, PKCδ is unique in that its overexpression results in inhibition of cell growth 
and initiation cell differentiation (Miyamoto et al., 2002). Because of the reasons 
mentioned above, one could imagine that LIF-induced PKC/PKCδ activation promotes 
cortical neuronal differentiation not only by enhancing NeuroD transcription, but also by 
enhancing GAP-43 phosphorylation. Furthermore, it would be therefore also of interest to 
demonstrate how dependent (or independent) both events are on (of) each other.  
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4.4 The role of Brg1 during mouse cortical neurogenesis 
 
Our  in vitro data showed that Brg1, a subunit of SWI/SNF chromatin 
remodeling protein complex, associates with the Ngn1/CBP transcriptional complex 
during cortical neurogenesis. In addition, we showed that LIF could enhance even this 
association. Seo et al (2005) previously demonstrated that in Xenopus Brg1 binds to Ngn, 
which, in turn, induces activation of target genes during neurogenesis. In contrast, 
Matsumoto et al. (2006) showed that in mice Brg1 is not expressed during early 
neurogenesis, until E13, but then gets upregulated during late neurogenesis and 
gliogenesis. This group concluded that Brg1 is necessary for inducing the neurogenesis to 
gliogenesis switch, and also shows that Brg1 downregulation leads to precocious 
maturation of NPCs. In addition, the same group also observed a dramatic loss of 
neurons, and abnormalities in cortical layering and pyramidal neuron morphology Brg1-
deficient E18 cortices. The authors conclude that this loss was likely due to, first, a loss 
of trophic support as a result of the loss of glia, which were also less expressed in Brg1 
mutants, and second, because many NPCs were already exhausted before E14. However, 
our results indicate that Brg1 is probably necessary during neurogenesis in the mouse 
cortex. Further support for this hypothesis comes from Gerald Crabtree’s group (Lessard 
et al., 2007). In their recently published paper, the authors showed that Brg1, depending 
on the subunit that it is bound to, is necessary for NPC proliferation as well as neuronal 
differentiation. When Brg1 was bound to Brg/Brm-associated factor 45a (BAF45a) or 
BAF53a, NPCs remained in a proliferative state by inducing the expression of several 
components of the Notch signaling pathway. On the other hand, as soon as BAF45b/c or   69
BAF 53b bound to Brg1 neuronal differentiation was induced. It would therefore be very 
interesting to investigate first, whether Brg/Ngn association is required for Ngn’s 
transcriptional activity, second, whether binding of Brg1 to Ngn requires BAF 45b/c, and 
BAF53b, and third, whether BAF 45a/53a expression abolishes Ngn1-Brg1 association. 
In addition, it would be interesting to see whether BAF 43b/c and BAF53b are part of the 
Ngn/CBP/Brg cotranscriptional complex. 
 
 
4.5 In vivo evidence for LIF’s pro-neural role during mouse cortical 
neurogenesis  
 
Upon demonstrating the pro-neurogenic effects of LIF in vitro, we next 
examined the effect of LIF on cortical neurogenesis by taking an in vivo “loss of 
function” approach. Specifically, we compared the cortical tissue from E13, LIF 
knockout (KO), LIF heterocygote (Het), and wildtype (WT) mice with regards to neuron-
specific markers. While immunohistochemistry of coronal brain sections showed 
seemingly unchanged neuronal differentiation pattern in all three genotypes, western blot 
analysis, a more quantitative method, showed that cortical tissue from LIF KO and Het 
mice contained less neurons as suggested by the decreased protein levels of neuronal 
markers, such as class III β-tubulin (TuJ1) and MAP2a/b, but not MAP2c.  While 
MAP2c is predominantly found in growing dendrites of immature neurons, the isoforms 
MAP2a and MAP2b are expressed in dendrites of mature neurons (Belanger et al, 2001; 
Don et al., 2004)). Class III β-tubulin, recognized by the antibody TuJ1, has been shown   70
to be a marker for postmitotic, immature/mature neurons of the CNS very early, during or 
immediately after the last mitotic cycle (Lee et al., 1990). However, the obtained results 
are supporting the idea that LIF promotes neuronal maturity during mouse cortical 
development. Though genes such as Ngn1 and Ngn2 are well known for being initiators 
of neuronal differentiation, genes like NeuroD are involved in mediating terminal 
differentiation. Taken together, our data suggest that once Ngn is expressed in cortical 
NPCs, it mediates the transcription of terminal differentiation bHLH factor NeuroD under 
positive regulation of LIF, resulting in neuronal differentiation/maturation to 
appropriately build the functional CNS. 
As previously shown, knocking out individual cytokines did not produce a 
phenotype that is notably different from wildtype with regards to gliogenesis, but 
blocking the action of the entire cytokine family (e.g., by knocking out gp130 or its 
coreceptor LIFR) led to a deficit in astrocyte formation (Koblar et al., 1998; Nakashima 
et al., 1999). These data indicate that, in single knockout mice, compensatory 
mechanisms might occur, as has been described for motor neuron survival (Sendtner et 
al., 1996; Holtmann et al., 2005). It might be therefore possible that these compensatory 
mechanisms also occur in LIF KO/Het mice during cortical neurogenesis, and factors 
such as CNTF may partially compensate for the lack of LIF. Based on this possibility, it 
might be conceivable that LIF/CNTF KO/Het mice may display even less class III β-
tubulin and/or MAP2a/b expression in the E13 cortex.  
Furthermore, it might be also of interest to elucidate the effect of LIF and Ngns 
on other inducible genes. For example, one of the downstream effectors regulated by 
Ngn2 in developing cortical neurones is neuroligin 1,  a  postsynaptic cell adhesion   71
molecule that has been shown to contribute to synapse maturation and function (Mattar et 
al., 2004; Varoqueaux et al., 2006). Berninger et al. (2007) made recently the observation 
that  Ngn2-expressing neurones undergo synaptogenesis more readily compared with 
controls or Mash1-transduced cells, which may thus be accounted for by the capacity of 
Ngn2 to upregulate neuroligins. It might be possible that LIF plays a positive-regulator 
role in this process as well.  
 
 
4.6 Implication of this work for regenerative medicine 
 
The results of this work might have an impact on studies that focus on the 
generation of neurons suitable for stem cell therapy. For example, Parkinson’s disease 
is characterized by the progressive loss of dopominergic (DA) neurons in the substantia 
nigra of the midbrain. Transplantation of DA neuron precursors into the brain of 
patients suggests that neuronal replacement therapy may be a possible treatment for 
Parkinson’s disease (Lindvall et al., 2004). Recently, Andersson et al. (2007) showed 
that overexpression of both Ngn2 and Nurr1 in combination was required to promote 
the generation of DA neurons from expanded multi-passaged neurosphere cultures, 
which originated from the ventral midbrain, with Nurr1 being a transcription factor that 
is involved in establishing the DA neurotransmitter identity in midbrain DA neurons 
(McKay, 2004; Zetterstrom et al., 1997). However, the number of DA neurons was still 
limited, and one could imagine that treatment of these cells with LIF might even further 
promote the generation of DA neurons in vitro.   72
The case above was just one example for the potential impact that LIF might 
have in generating large amounts of specific neurons. Nevertheless, understanding the 
molecular control of neuronal differentiation will allow us to direct the differentiation 
of neural stem cells more efficiently, so that these cells will be suitable in cell 
replacement therapies for patients suffering from neurodegenerative disorders such as 
Parkinson’s and Alzheimer’s disease  
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5. Zusammenfassung 
 
Die Entwicklung von unterschiedlichen Zelltypen waehrend der embryonalen 
ZNS-Entwicklung ist abhaengig von zellintrinsischen und positionsabhaengigen, 
aeusseren Einfluessen. Dabei bilden sich die verschiedenen Zellen in nacheinander 
ablaufenden bzw. sich teilweise ueberlappenden Zeitraeumen. Zuerst entstehen Radiaglia 
und Neuronen, nachfolgend Astrozyten und zuletzt Oligodendrozyten. Werden neurale 
Stammzellen/Vorlaeuferzellen (NPCs – neural precursor cells) zu unterschiedlichen 
Zeitpunkten entnommen und ohne den Einfluss von Wachstumsfaktoren kultiviert, so 
entwickeln sich diese Zellarten in der gleichen Reihenfolge.  
Die Neurogenese, die bei Mausembryos am Tag E11-12, nach dem Etablieren 
der Radialglia, beginnt, findet an E14 ihren Hoehepunkt. Zu diesem Zeitpunt werden die 
Gene  Neurogenin1 ( Ngn1) und Ngn2 in den neuralen Vorlaeuferzellen der 
Ventrikularzone des dorsalen Cortexes in hohem Masse exprimiert. Wie aus 
Untersuchungen von unserm Labor gezeigt wurde, beguenstigt es die Entstehung von 
Neuronen und blockiert gleichzeitig Pro-Astrozyten-Einfluesse. Zum einen inhibiert Ngn 
den JAK/STAT Signalweg, dessen Aktivierung fuer die Gliogenese noetig ist, indem es 
die Phosphoylierung von STAT1/3 auf bisher noch unbekannte Weise blockiert. 
Ausserdem bindet der Transkriptions-Coaktivator cAMP-response element binding 
protein (CBP), welches auch von den STATs fuer die Transkription benoetigt wird, 
bevorzugt an Ngn sobald dieses von den Vorlaeuferzellen exprimiert wird.   
Mit dem Tag E16 nimmt die Neurogenese in vivo wieder stark ab und es setzt 
die Gliogenese ein, bei der zunaechst ueberwiegend Astrozyten gebildet werden.   74
Faktoren wie leukemia inhibitory factor (LIF) sowie ciliary neurotrophic factor (CNTF) 
beguenstigen dabei die Astrozytogenese indem sie den JAK/STAT Signalweg aktivieren. 
Die Bindung von LIF/CNTF fuehrt zur Phosphorylierung von STAT-
Transkriptionsfaktoren, die ihrerseits dann an den CBP/p300 Komplex binden und 
schliesslich die Expression von Astrozyten-spezifischen Genen aktivieren. Die STAT-
Faktoren koennen aber erst nach Abfall des Ngn-Spiegels an den Transkriptions-
Coaktivator binden, da sich die Bindungsstellen dieser beiden ueberlappen. 
Um die Hypothese zu ueberpruefen, dass LIF auch die Neurogenese, oder 
spezifischer, die Wirkung von Ngn positiv beeinflusst, wurden cortikale NPCs von 
murinen Embryos entnommen und der Wirkung von LIF via Luciferase Assay 
untersucht. Dabei wurden die Vorlaeuferzellen mit Ngn und einem Reporter transfiziert, 
welcher den NeuroD-Promoter beinhaltete. NeuroD-Expression findet in der Regel gegen 
Mitte/Ende der Neurogenese statt und ist wichtig fuer die Reifung von Neuronen. Der 
Promoter von NeuroD beinhaltet ein E-box Element, an welches Ngn bindet und die 
Transkription einleitet. Wie unsere ersten Versuche zeigten, verstaerkt LIF die 
Transkriptionsaktivitaet von Ngn und somit die Transkription von NeuroD. Wenn aber im 
selben Versuch ein NeuroD-Reporter transfiziert wurde, dessen E-box mutiert war, wurde 
keine Transkriptionsaktivitaet gemessen, was wiederum bestaetigte, dass der pro-neurale 
LIF-Effekt ueber Ngn lief und E-box-Bindung noetig war.       
Um den Einfluss des pro-neuralen Effekts von LIF auf Proteinebene zu testen, 
wurden NPCs mit Ngn-Adenovirus infiziert und mit LIF stimuliert. Dabei wurden die 
Zellen auf die Expression von Neuron-spezifischem class III β-tubulin (TuJ1) untersucht. 
Die Ergebnisse zeigten, dass LIF bei Zellen, die Ngn exprimierten, die Rate der Neuronen   75
von etwa 5% auf etwa 50% anstiegen liess, waehrend LIF bezueglich der Gliogenese 
(gezeigt durch die Expression von GFAP) in Ngn-exprimierenden Vorlaeuferzellen kaum 
Wirkung zeigte.  
Als naechstes sollte untersucht werden ueber welchen Signalweg LIF Ngn 
aktivierte. LIF bindet zunaechst an LIF receptor β (LIFRβ), der dann an glycoprotein 130 
(gp130) bindet. Diese Bindung fuehrt dann zur Aktivierung mehrerer Signalkaskaden: 
dem JAK/STAT,  dem MAPK, dem Akt/PI3K und dem PLCγ/PKC Signalweg. Da der 
JAK/STAT Signalweg fuer die Gliogenese wichtig ist, lag unser Fokus auf den anderen 
Signalwegen. Deren Aktivierung wurde dann mit spezifischen Inhibitoren  blockiert und, 
wie auch in den Vorversuchen, die Wirkung von LIF auf Transkriptionsebene (NeuroD) 
in neuralen Vorlaeuferzellen bestimmt. Dabei zeigte sich, dass die Blockierung des 
PLCγ/PKC Signalweges die NeuroD-Promoteraktivitaet am starksten inhibierte, 
waehrend auch LIF´s pro-neurale Wirkung verloren ging. Dementsprechend zeigte die 
Western Blot Analyse, dass die Expression von class III β-tubulin (TuJ1) durch die 
Anwendung der PKC Inhibitoren am staerksten inhibiert wurde, wobei auch hier die 
Stimulation durch LIF keine erhoehte Neurogenese mit sich zog.     
In weiteren Versuchen konnten wir dann mit Hilfe von Immunoprezipitation 
demonstrieren, dass LIF die Bindung von Ngn an CBP verstaerkte (eine Bindung, welche 
durch PKC Inhibitoren aufgehoben wurde), was wiederum zu einer erhoehten Bindung 
dieses Transkriptionskomplexes an den NeuroD Promoter fuehrte, wie unsere Chromatin 
Immunoprezipitation (ChIP) Daten beweisen. Dies wiederum laesst darauf schliessen, 
dass womoeglich diese erhoehte Ngn-CBP/NeuroD-Promoter Bindung der Grund fuer die 
erhoehte  NeuroD-Transkriptionsaktivitaet ist daher auch fuer die erhoehte neuronale   76
Differenzierung. Interessanterweise konnten wir auch zeigen, dass Brahma-related gene 1 
(Brg1),  eine katalytische Untereinheit des  SWI/SWF Komplexes, an den Ngn/CBP 
cotranscriptionalen Komplex bindet und dass diese Bindung durch LIF-Stimulation 
verstaerkt wurde. Dies suggeriert wiederum, dass auch Brg1 eine wichtige Rolle 
waehrend der murinen, cortikalen Neurogenese spielt. Dennoch, in folgenden 
Experimenten verblieb der Fokus auf Ngn und CBP.  
Um unsere Hypothese zu bestaetigen, dass PKCδ ein moeglicher Mediator des 
LIF-Effekts sein koennte, zeigten wir zunaechst, dass die PKCδ-Expression in cortikalen 
NPCs waehrend der Neurogenese erhoeht ist. Desweiteren demonstrierten wir, dass die 
Inhibition von PKCδ einen aehnliche Wirkung zeigte wie die Inhibition von PKC mit 
einem generellen PKC Inhibitor: weder war nach PKCδ-Inhibition eine LIF-induzierte 
NeuroD-Transkription erzielbar, noch wurde nach LIF-Stimulation der pro-neurale 
Marker class III β-tubulin/TuJ1 in Ngn1-infizierten NPCs exprimiert. Um aber mehr 
spezifisch die PKC- und PKCδ-Aktivitaet/Expression zu blockieren transfizierten wir 
NPCs mit PLCγ oder PKCδ siRNA.  Unsere Daten zeigten hierbei, dass siRNA-
transfizierte Zellen kein class III β-tubulin mehr aufweisen, was darauf hindeuted, dass 
PKCδ der potentielle Mediator des pro-neuralen LIF-Effekts ist. 
Durch unsere in vivo Daten demonstrierten wir schliesslich, dass LIF auch 
hierbei fuer die Neurogenese von Bedeutung ist. Verglichen wurden die Cortices von E13 
LIF Het (heterozygote) und KO (knock out) Maeusen mit denen von WT (wild type) 
Maeusen. Durch Immunohistologie von Hirnschnitten konnten dabei keine groesseren 
Unterschiede bezueglich der Expression neuraler Marker beobachtet werden, waehrend 
aber mit Hilfe der Western Blot Analyse, eine quantitativere Methode, gezeigt wurde,   77
dass LIF Het und KO Maeuse  weniger pro-neurale Marker im Cortex exprimieren wie 
WT Mause. Um auch zu beweisen, dass dies auf eine verringerte Transkription von 
NeuroD zurueckzufuehren ist, demonstrierten wir mit Hilfe des ChIP Assay, dass LIF 
Het und KO Maeuse weniger Ngn1-CBP Bindung an den NeuroD-Promoter aufweisen 
wie WT Maeuse. 
Diese Experimente veranschaulichen einen eleganten Regulationsmechanismus, 
durch welchen ein einzelner, extrazellulaerer Faktor die unterschiedliche Differenzierung 
einer Zelle verstaerkt, abhaengig von der Anwesenheit oder Abwesenheit eines 
einzelnenn intrazellulaeren Faktors. Auch koennen durch die erlangten Resultate 
Strategien entworfen werden, durch die in Zukunft die Produktion bestimmter Neurone 
zur Heilung von verschiedenen, neurodegenerativen Krankheiten erhoeht wird. 
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